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Chapter 1 
Introduction 
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1.1 Congenital heart disease 
In the Netherlands each year 200.000 children are born according to figures from the Centraal 
Bureau voor de Statistiek. Approximately 2-3% of these children is affected with a congenital 
malformation, of which heart defects account for 20-25% 1. This means that each year 
approximately 1400 children are born with a congenital cardiovascular malformation 1. These 
malformations are the result of aberrant embryonic development of a normal structure, or 
failure of such a structure to progress beyond an early stage of embryonic or fetal 
development. The aetiology is still largely unclarified. Between 6-10% is attributed to genetic 
factors, 1% to toxic factors and 1% to intra-uterine infections 2. In the majority of cases 
complex multifactorial genetic factors in combination with environmental influences are 
thought to be responsible 3.  
Over the last decades therapeutic interventions have greatly improved and 85% of all children 
with congenital heart disease reach adulthood 4. However, despite the advances in medical 
and surgical treatment, congenital heart disease still accounts for the largest component of 
infant mortality. Approximately 12% of all infants that die within the first year of life suffer 
from congenital heart disease 5. After successful surgical repair many patients experience 
morbidity, sometimes accompanied by limited life expectancy 6. Most frequent sequelae of 
congenital heart disease in adults are cardiac arrhythmias, valve insufficiency, pulmonary 
hypertension, endocarditis, and heart failure. These patients need life-long surveillance of 
their cardiac condition. In order to improve surgical outcome and the care for the 
(postoperative) adult patient we must increase our understanding of normal and abnormal 
cardiovascular developmental mechanisms.  
 
1.2 The chick embryo model 
In humans the heart is completely developed by the 10th week of pregnancy. This means that 
the embryonic heart has developed from a muscle wrapped tube into a septated four-
chambered heart at the time most women undergo their first ultrasound scan. Moreover, the 
available ultrasound techniques do not allow a very detailed morphological examination of 
the heart until week 11 7. Thus to investigate cardiovascular development in vivo we need an 
animal model. We chose the chick embryo because it shares morphological characteristics of 
the human embryo during early cardiac development 8. Furthermore, the chick embryo model 
is a relatively cheap model and due to its independency of the mother hen, it is also very 
accessible for manipulations. 
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The chick embryo has been used as a model to study hemodynamics and cardiovascular 
development for many decades. Chick embryonic development is completed in 21 days. 
Hamburger and Hamilton (HH) divided this period into 46 developmental stages based on 
morphological landmarks 9. Using this classification system the developmental age of each 
embryo can be established accurately. 
The heart is the first organ that forms and functions in the embryo. At HH10 (33-38hrs) the 
first heartbeat is detected and at HH12 (45-49hrs) blood flow is present. The heart is 
responsible for pumping blood to the embryo and the extra-embryonic circulation that 
provides the embryo with oxygen and nutrients and removes waste products. This means that 
its function is already crucial during the complicated process of cardiac development. Thus 
forces generated by cardiac contraction and relaxation, for instance blood pressure and blood 
flow, likely influence cardiovascular development 10.   
The embryo grows rapidly. Embryonic weight increases 120-fold between HH12 and HH29 
from 2.2 to 267.5mg and ventricular weight shows a 30-fold increase from 0.10 to 3.18mg 10. 
Dorsal aortic blood flow increases parallel with embryonic growth 10, whereas the relative 
weight of the ventricle decreases 11. This suggests that somehow cardiac output and metabolic 
demands are precisely coupled and that the cardiovascular system becomes increasingly 
effective.  
Blood pressure waveforms are strikingly similar to those in mature circulations. The atrial 
pressure curve has a distinct A-wave. The ventricular pressure curve has a characteristic early 
diastolic passive rise and late diastolic active atrial accentuation 10. Ventricular systole 
consists of an isovolumic contraction phase, ejection phase and isovolumic relaxation phase. 
The arterial pressure waveform shows distinct diastolic and systolic pressures, including a 
dicrotic notch 10. 
Cardiac function in the embryo and adult animal is determined by preload, afterload, heart 
rate and myocardial contractility. Preload depends on the diastolic phase, in which the 
ventricle is filled with blood. Diastole can be partitioned into a passive filling component and 
an active filling component. During the passive phase blood flows from the atrium to the 
ventricle due to the pressure-gradient 12. Hereafter, active filling is established by atrial 
contraction. During development the ratio of passive to active filling volume decreases 
because the active filling increases geometrically 13. The atrioventricular flow pattern may 
influence ventricular chamber growth and thus may determine ventricular chamber volume 13. 
Cardiac output depends on preload. In early stages of development the autonomic nervous 
system is not present yet 14,15 and cardiac output is controlled by the Frank-Starling 
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mechanism as in the human foetus 16. Wagman et al. 17 demonstrated the presence of this 
mechanism in the chick embryo by volume injections that lead to increased dorsal aortic 
blood velocity and stroke volume. 
Afterload, the force against which the ventricle contracts, decreases during development as 
the vascular bed grows rapidly 18. Vascular resistance may be also controlled by receptor-
mediated changes in vascular tone. Injections with ß-adrenergic agonists resulted in increased 
vascular resistance 19. Atrial natriuretic peptide (ANP) causes vasodilatation and a decrease in 
passive filling resulting in decreased preload and cardiac output 20,21.  
Heart rate increases from about 103 bpm at HH12 to more than 239 bpm at the time the 
embryo hatches 10,22. Heart rate influences filling characteristics of the ventricle. Experimental 
pacing faster than intrinsic heart rate leads to a decrease in stroke volume, due to a reduction 
in passive filling 23, which can be reversed by volume loading during pacing 24. This is again 
probably the result of the Frank-Starling principle. Environmental factors like temperature 
also influence cardiac function profoundly 25,26. An increase in temperature results in an 
increase in heart rate, cardiac output and a decrease in vascular resistance, while a decrease in 
temperature results in opposite effects. Stroke volume seems not to be influenced, as it 
remains constant during temperature changes.  
Myocardial contractility is the inherent capacity of the myocardium to contract independently 
of changes in preload or afterload. It is largely dependent on the amount of calcium reaching 
the myofilaments and the quantity and quality of myofilaments 27. Pump performance 
increases with development, which is probably due to a better organization and more orderly 
arrangement of the myofibrils leading to increased myocardial contractility 28,29.  Also 
maturation in the calcium transport system could play a role 30.  
As outlined earlier, cardiac function is already crucial during the complicated process of 
cardiac development. There seems to be an intricate relationship between form and function. 
Several studies have shown that alterations in hemodynamics can precede the onset of 
structural cardiac defects 31,37. It is likely that blood pressure and blood flow are important 
determinants for development of the heart and vessels and that the final organization of the 
myocardium is in part determined by hemodynamic forces interacting with the developing 
ventricular walls 29. Knowledge of developmental mechanisms is the key to understanding the 
link between aetiological factors and cardiac malformations 32.   
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1.3 The venous clip model 
In 1997 Bianca Hogers and co-workers designed an intervention model for the chick embryo 
at the department of Anatomy and Embryology of the Leiden University Medical Center to 
obtain insight into the long-term hemodynamic effects of mechanical manipulation at the 
venous pole of the heart. She studied intracardiac blood flow patterns and their relation to the 
yolk sac circulation using India ink injections 33. She described that blood derived from 
specific yolk sac regions follows specific developmental stage-dependent intracardiac routes. 
Permanent obstruction of the right lateral vitelline vein (venous clipping) with a microclip 
causes alterations in these intracardiac flow patterns 34. Furthermore, after venous clipping the 
embryos displayed specific cardiovascular malformations consisting of a spectrum of outflow 
tract anomalies like ventricular septal defects, valve anomalies and pharyngeal arch artery 
malformations 34,35. Next to the morphological malformations, Broekhuizen et al. also 
demonstrated long-term hemodynamic changes after venous clipping 36. At HH34 (day 8 of 
incubation) heart rate was decreased, whereas peak systolic and mean systolic velocities, as 
well as peak and mean blood flow were increased after clipping 36. However, at this point 
(HH34) cardiac malformations are already present, which makes it impossible to determine 
whether these hemodynamic changes are a direct effect of the clipping procedure or are 
caused by the cardiac malformations. The fact that intracardiac blood flow patterns change 
directly after clipping suggests that hemodynamics is influenced by this procedure and that 
hemodynamics plays a role in cardiac development 35. Other studies have also shown that 
alterations in hemodynamics can precede the onset of structural defects 31,37. Clipping causes 
a detour of venous inflow to the heart. After clipping, venous blood that is normally drained 
by the right lateral vitelline vein to the heart is redirected to the posterior vitelline vein via a 
small capillary vessel, which expands into a large anastomosis within a few hours. Hogers et 
al. 34 postulated that alterations in hemodynamic parameters could lead to changes in shear 
stress, which could alter the expression of shear stress responsive genes with downstream 
alterations in developmental processes resulting in cardiac malformations. Shear stress (τ) is 
the frictional force from blood flow on the endothelium, which can be calculated as follows: τ 
= 4µQ/πR³, in which µ is viscosity of blood, Q blood flow and R blood vessel radius. 
Endothelial cells sense changes in shear stress, which lead to changes in gene expression by 
activation of a shear stress responsive element in the promotor region of the gene 38. The exact 
mechanism explaining how endothelial cells sense changes in shear stress is not clear yet. In a 
review by Resnick et al. 39 several endothelial proteins and structures termed shear stress 
sensors/receptors/transducers, localised to various compartments of the endothelial cell, are 
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described: cell-matrix and cell-cell junction molecules, membrane structures like ion channels 
and G-proteins, and the endothelial cytoskeleton 39. After sensing a change in shear stress, 
second messenger cascades are activated leading to activation of shear stress responsive 
elements and activation or modulation of other transcription factors eventually affecting gene 
expression 40. Endothelin-1 (ET-1), expressed by the endothelial cells, is a growth factor, 
which is shear stress responsive and part of the endothelin-1/endothelin-converting-
enzym/endothelin-A receptor (ET-1/ECE-1/ETA) signalling cascade 38,41. This cascade is 
important in cardiac development 42. Cardiovascular malformations in the venous clip model 
are similar to malformations observed in knockout mice studies of the endothelin pathway 42-
44. This suggests that the endothelin pathway might be involved in the development of 
malformations induced by venous clipping. 
 
In humans, complex multifactorial genetic factors in combination with environmental 
influences are held responsible for the development of cardiovascular malformations in the 
majority of cases 3. These combinations lead to altered gene and protein expression, which in 
turn can lead to hampered blood flow patterns inside the embryonic heart. Both altered gene 
expression and hampered blood flow may result in cardiovascular malformations as described 
in the venous clip model. The venous clip model enables us to study the consequences of 
altered flow patterns on cardiovascular morphological and functional development. 
Based on these prior studies regarding the development of cardiovascular malformations in 
the venous clip model we explored the following hypothesis in the present thesis. Venous 
clipping leads to instantaneous alterations in hemodynamic parameters, which cause changes 
in shear stress responsive gene expression, resulting in development of both long-term 
functional cardiac impairment and malformations. We also hypothesize that endothelin-1 is 
involved in the disturbed development in this model. The ultimate goal is to elucidate the 
relationship between cardiac morphogenesis and cardiac function. 
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1.4 Research objectives 
We started this research project in order to learn more about cardiac function during 
embryonic development, and especially about the intricate relationship between cardiac 
morphogenesis and cardiac function. The venous clip model enabled us to study the influence 
of altered venous return patterns on hemodynamic parameters and cardiac morphogenesis. 
The objectives of this thesis were as follows: 
 
1. To study the instantaneous effects of clipping the right lateral vitelline vein on volume 
flow in the stage 17-chick embryo using dorsal aortic Doppler measurements. Data are 
presented in chapter 3. 
 
2. To determine the long-term consequences of the venous clip intervention for ventricular 
function as assessed by pressure-volume loop analysis one day (HH21) and two days 
(HH24) after the clip intervention. This is discussed in chapter 4.1 and 4.2 respectively. 
 
3. To assess the influence of the venous clip intervention on ventricular diastolic filling 
characteristics at stage 24 using simultaneous Doppler measurements over the dorsal 
aorta and atrioventricular canal. This is presented in chapter 5.1. 
 
4. To establish the influence of endothelin-1 or endothelin receptor antagonist infusion on 
ventricular diastolic filling characteristics at stage 24 using simultaneous Doppler 
measurements over the dorsal aorta and atrioventricular canal. Results are discussed in 
chapter 5.2. 
 
   16
1.5 References 
1. Eurocat Website Database: www.eurocat.ulster.ac.uk, University of Ulster, 2003. 
2. Buskens E, Grobbee DE, Frohn-Mulder IM, Wladimiroff JW, Hess J. Aspects of the aetiology 
of congenital heart disease. Eur Heart J. 1995;16:584-7. 
3. Nora JJ. Causes of congenital heart diseases: old and new modes, mechanisms, and models. 
Am Heart J. 1993;125:1409-19. 
4. Vriend JW, van der Velde ET, Mulder BJ. National registry and DNA-bank of patients with 
congenital heart disease: the CONCOR-project. Ned Tijdschr Geneeskd. 2004;148:1646-7. 
5. Factsheet: cijfers en feiten aangeboren hartafwijkingen. The Netherlands Heart Foundation, 
1998. 
6. Mulder BJM. Inleiding. In: Mulder BJM, Pieper PG, Spitaels SEC, eds. Aangeboren 
hartafwijkingen bij volwassenen. Houten/Diegem: Bohn Stafleu Van Loghum; 1999. 
7. Haak MC, Twisk JW, Van Vugt JM. How successful is fetal echocardiographic examination 
in the first trimester of pregnancy? Ultrasound Obstet Gynecol. 2002;20:9-13. 
8. Sissman NJ. Developmental landmarks in cardiac morphogenesis: comparative chronology. 
Am.J.Cardiol. 1970;25:141-148. 
9. Hamburger V, Hamilton HL. A series of normal stages in the development of the chick 
embryo. J Morphol. 1951;88:49-92. 
10. Hu N, Clark EB. Hemodynamics of the stage 12 to stage 29 chick embryo. Circ Res. 
1989;65:1665-1670. 
11. Clark EB, Hu N. Hemodynamics of developing cardiovascular system. Ann.N.Y.Acad.Sci. 
1990;588:41-47. 
12. Clark EB. Hemodyanmic control of the embryonic circulation. In: Clark EB, Takao A, eds. 
Developmental cardiology: Morphogenesis and function. New York: Futura Publishing Co.; 
1990:291-303. 
13. Hu N, Connuck DM, Keller BB, Clark EB. Diastolic filling characteristics in the stage 12 to 
27 chick embryo ventricle. Pediatr Res. 1991;29:334-337. 
14. Pappano AJ. Ontogenetic development of autonomic neuroeffector transmission and 
transmitter reactivity in embryonic and fetal hearts. Pharmacological Reviews. 1977;29:3-33. 
15. Higgins D, Pappano AJ. Developmental changes in the sensitivity of the chick embryo 
ventricle to beta-adrenergic agonist during adrenergic innervation. Circ Res. 1981;48:245-53. 
16. Ursem NTC, Struijk PC, Hop WCJ, Clark EB, Keller BB, Wladimiroff JW. Heart rate and 
flow velocity variability as determined from umbilical Doppler velocimetry at 10-20 weeks of 
gestation. Clin.Sci. 1998;95:539-545. 
17. Wagman AJ, Hu N, Clark EB. Effect of changes in circulating blood volume on cardiac output 
and arterial and ventricular blood pressure in the stage 18, 24 and 29 chick embryo. Circ Res. 
1990;67:187-192. 
   17
18. Clark EB, Hu N. Developmental hemodynamic changes in the chick embryo from stage 18 to 
27. Circ Res. 1982;51:810-815. 
19. Clark EB, Hu N, Dooley JB. The effect of isoproterenol on cardiovascular function in the 
stage 24 chick embryo. Teratology. 1985;31:41-7. 
20. Nakazawa M, Kajio F, Ikeda K, Takao A. Effect of atrial natriuretic peptide on hemodynamics 
of the stage 21 chick embryo. Pediatric Research. 1990;27:557-560. 
21. Hu N, Hansen AL, Clark EB, Keller BB. Effect of atrial natriuretic peptide on diastolic filling 
in the stage 21 chick embryo. Pediatr Res. 1995;37:465-8. 
22. Broekhuizen MLA, Mast F, Struijk PC, Bie van der W, Mulder PGH, Gittenberger-De Groot 
AC, Wladimiroff JW. Hemodynamic parameters of stage 20 to stage 35 chick embryo. Pediatr 
Res. 1993;34:44-46. 
23. Dunnigan A, Hu N, Benson DW, Clark EB. Effect of heart rate increase on dorsal aortic flow 
in the stage 24 chick embryo. Pediatr. Res. 1987;22:442-444. 
24. Benson DW, Jr., Hughes SF, Hu N, Clark EB. Effect of heart rate increase on dorsal aortic 
flow before and after volume loading in the stage 24 chick embryo. Pediatr Res. 1989;26:438-
41. 
25. Nakazawa M, Clark EB, Hu N, Wispé J. Effect of environmental hypothermia on vitelline 
artery blood pressure and vascular resistance in the stage 18, 21, and 24 chick embryo. Pediatr 
Res. 1985;19:651-4. 
26. Nakazawa M, Miyagawa S, Takao A, Clark EB, Hu N. Hemodynamic effects of 
environmental hyperthermia in stage 18, 21, and 24 chick embryos. Pediatr Res. 
1986;20:1213-5. 
27. Nakanishi T, Seguchi M, Takao A. Development of the myocardial contractile system. 
Experientia. 1988;44:936-944. 
28. Manasek FJ. Histogenesis of the embryonic myocardium. Am J Cardiol. 1970;25:149-68. 
29. Clark EB, Hu N, Dummett JL, Vandekieft GK, Olson C, Tomanek R. Ventricular function and 
morphology in chick embryo from stages 18 to 29. Am J Physiol. 1986;250:H407-H413. 
30. Cheanvechai V, Hughes SF, Benson DW, Jr. Relationship between cardiac cycle length and 
ventricular relaxation rate in the chick embryo. Pediatr Res. 1992;31:480-2. 
31. Stewart DE, Kirby ML, Sulik KK. Hemodynamic changes in chick embryos precede heart 
defects after cardiac neural crest ablation. Circ Res. 1986;59:545-550. 
32. Clark EB. Cardiac embryology. Its relevance to congenital heart disease. Am J Dis Child. 
1986;140:41-4. 
33. Hogers B, DeRuiter MC, Baasten AM, Gittenberger-de Groot AC, Poelmann RE. Intracardiac 
blood flow patterns related to the yolk sac circulation of the chick embryo. Circ Res. 
1995;76:871-7. 
   18
34. Hogers B, DeRuiter MC, Gittenberger-de Groot AC, Poelmann RE. Unilateral vitelline vein 
ligation alters intracardiac blood flow patterns and morphogenesis in the chick embryo. Circ 
Res. 1997;80:473-481. 
35. Hogers B, DeRuiter MC, Gittenberger-de Groot AC, Poelmann RE. Extraembryonic venous 
obstructions lead to cardiovascular malformations and can be embryolethal. Cardiovasc Res. 
1999;41:87-99. 
36. Broekhuizen ML, Hogers B, DeRuiter MC, Poelmann RE, Gittenberger-de Groot AC, 
Wladimiroff JW. Altered hemodynamics in chick embryos after extraembryonic venous 
obstruction. Ultrasound Obstet Gynecol. 1999;13:437-45. 
37. Harh JY, Paul MH, Gallen WJ, Friedberg DZ, Kaplan S. Experimental production of 
hypoplastic left heart syndrome in the chick embryo. Am J Cardiol. 1973;31:51-6. 
38. Malek AM, Izumo S. Control of endothelial cell gene expression by flow. J Biomech. 
1995;28:1515-28. 
39. Resnick N, Yahav H, Shay-Salit A, Shushy M, Schubert S, Zilberman LC, Wofovitz E. Fluid 
shear stress and the vascular endothelium: for better and for worse. Prog Biophys Mol Biol. 
2003;81:177-99. 
40. Topper JN, Gimbrone MA. Blood flow and vascular gene expression: fluid shear stress as a 
modulator of endothelial phenotype. Mol Med Today. 1999;5:40-46. 
41. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, 
Alexander RW, Murphy TJ. Molecular cloning and characterization of the constitutive bovine 
aortic endothelial cell nitric oxide synthase. J Clin Invest. 1992;90:2092-6. 
42. Kurihara Y, Kurihara H, Oda H, Maemura K, Nagai R, Ishikawa T, Yazaki Y. Aortic arch 
malformations and ventricular septal defect in mice deficient in endothelin-1. J Clin Invest. 
1995;96:293-300. 
43. Yanagisawa H, Yanagisawa M, Kapur RP, Richardson JA, Williams SC, Clouthier DE, de 
Wit D, Emoto N, Hammer RE. Dual genetic pathways of endothelin-mediated intercellular 
signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. 
Development. 1998;125:825-36. 
44. Clouthier DE, Hosoda K, Richardson JA, Williams SC, Yanagisawa H, Kuwaki T, Kumada 
M, Hammer RE, Yanagisawa M. Cranial and cardiac neural crest defects in endothelin-A 
receptor-deficient mice. Development. 1998;125:813-24. 
  
 
 
  
 
 
 
 
 
 
Chapter 2 
Methodology 
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This chapter describes the techniques and methods that were used to obtain different 
parameters of ventricular function in the chick embryo.  
 
2.1 The venous clip procedure 
At Hamburger and Hamilton stage 17 (2.5 days of incubation) the embryos were exposed by 
creating a window in the shell and removing the overlying membranes 1. Then the vitelline 
membrane was removed adjacent to the right vitelline vein and a small incision in the yolk sac 
membrane was made. Subsequently, the right vitelline vein was obstructed with an aluminium 
microclip (Fig. 1). The microclips were made of a 0.2mm aluminium sheet. Cessation of 
blood flow proximal to the microclip was confirmed under microscopic surveillance. All 
experiments were performed in ovo. After this intervention hemodynamic measurements were 
made and/or the embryo was reincubated until a later developmental stage. 
 
 
Figure 1. 
Chick embryo at HH17.  
The microclip obstructs the right lateral vitelline vein (rlvv) completely. 
 
 
microclip 
rlvv 
   21
2.2 Doppler ultrasound 
The principle of Doppler ultrasound lies in the Doppler effect. This natural phenomenon was 
first described by Christian Doppler, an Austrian physicist (1803-1853). When sound, emitted 
by an object, is received by a moving sound receiver then the frequency of the received sound 
is different from the original emitted signal. This is the Doppler shift. The change in 
frequency depends on the velocity of the moving receiver. We can use this relationship for 
determining blood flow velocities in chick embryos using a 20 MHz sound emitting pulsed 
Doppler probe. This Doppler probe serves as both emitter and receiver. The emitted signal is 
reflected by the red blood cells and its frequency is shifted by movements of the red blood 
cells. From the frequency shift the blood flow velocity is calculated using the following 
equation: 
V = (∆f . c) / (2 . f0 . cosα), 
where V is velocity of the blood flow, ∆f is the frequency shift, c is velocity of sound in 
tissue, f0 is emitted frequency and α is the angle of insonation of the probe. 
 
Dorsal aortic blood flow velocity measurements 
In practice, dorsal aortic blood flow velocity measurements were carried out as follows: A 20-
MHz pulsed Doppler meter (model 545C-4, Iowa Doppler Products, Iowa City, IA, USA) was 
used to measure the blood flow velocity. The Doppler audio signals were digitised at 12 kHz 
and stored on hard disk. Using complex fast Fourier transform analysis, the maximum 
velocity waveform was reconstructed. The Doppler probe consisting of a 750µm piezoelectric 
crystal was positioned at a 45º angle to the dorsal aorta at the level of the developing wing 
bud (Fig. 2). The sample volume was adjusted to cover the lumen of the dorsal aorta only, 
excluding other adjacent vessels. The internal aortic diameter was measured at the same level 
by video imaging with a stereo microscope (model SV 6, Carl Zeiss, Oberkochen, Germany) 
and a video camera (model SSC-M370CE, Sony Corporation, Tokyo, Japan). The video 
images were acquired with an image acquisition board (IMAQ PCI-1408, National 
Instruments, Austin, TX, USA) and subsequently analysed with a custom-built analysis 
program using IMAQ Vision software (National Instruments). Size calibration in the 
horizontal and vertical planes of the image was performed by videotaping a 10µm division 
scribed scale. For calculation of the aortic diameter, the magnification of the video image 
displaying the dorsal aorta was incorporated into the image analysis program.  
Blood flow was calculated from the equation Q=vπd2/4, where v is mean aortic blood flow 
velocity and d is the internal aortic diameter. Peak acceleration (dV/dt) was derived from the 
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dorsal aortic blood flow velocity by means of digital differentiation. Stroke volume was 
determined from the quotient of the dorsal aortic blood flow and the heart rate. Peak systolic 
velocity (PSV, mm/s), time-averaged velocity (TAV, mm/s), heart rate (bpm), peak blood 
flow (mm3/s), mean blood flow (mm3/s), peak acceleration (mm/s2) and stroke volume (mm3) 
were determined for each cardiac cycle. For each embryo a high quality waveform recording 
of 10 seconds was used for the analysis (fig.3). The 10-second recordings contained 20-27 
heartbeats. For all hemodynamic parameters in each embryo, the average of all cardiac cycles 
was calculated.  
 
 
 
 
 
Figure 2. HH17 chick embryo. 
This figure demonstrates the Doppler probe 
covering the dorsal aorta, positioned at the level of 
the developing wing bud of a normal stage 17-
chick embryo. 
 
 
 
 
 
Figure 3. 
Dorsal aortic blood flow velocity waveform of a stage 17 chick embryo.  
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Atrioventricular blood flow velocity measurements 
To assess diastolic filling characteristics the atrioventricular (AV) blood flow velocity was 
measured with a second crystal positioned at the apex of the heart towards the AV orifice 
(Fig. 4). The Doppler audio signals from both the dorsal aorta and AV canal were digitized at 
24 kHz and stored on hard disk. Passive filling (P) was defined in the AV flow velocity 
waveform from end-systole to the onset of the A-wave, and active filling (A) from the onset 
of the A-wave to the onset of systole (Fig. 5). Portions of passive and active filling overlapped 
each other at faster heart rates. The demarcation between the passive and active velocities was 
dependent on heart rate, but was most conspicuous at slower heart rate. Embryos were studied 
at similar heart rates to avoid the effect of heart rate on diastolic filling. Cycle length was 
defined as the time between consecutive beats obtained from the dorsal aortic velocity 
waveform. Dorsal aortic and both passive and active AV velocity profiles were integrated 
over time. Dorsal aortic blood flow was calculated as the product of the integrated velocity 
curve and the cross-sectional area of the dorsal aorta. Passive ventricular filling volume 
equaled dorsal aortic stroke volume multiplied by the fraction of passive filling area and 
active ventricular filling volume equaled dorsal aortic stroke volume multiplied by the 
fraction of the active filling area 2.  
 
 
 
 
 
 
 
 
 
Figure 4.  
HH24 chick embryo. 
Simultaneous Doppler measurements of the 
dorsal aorta and the atrioventricular canal. 
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Figure 5.  
Simultaneously acquired dorsal aortic blood flow (grey line) and atrioventricular blood flow velocity 
(black line). The diastolic phase consists of a passive (P) phase and an active (A) phase. 
 
Reproducibility study of flow velocity waveforms in the chick embryo  
To validate the method by which we obtained the velocity waveform recordings of the dorsal 
aorta in chick embryos using a 20-MHz pulsed Doppler meter, we conducted a study to assess 
the reproducibility. We measured 10 embryos of HH17 that showed no bleeding or 
deformities. All experiments were performed in ovo. In each of the 10 embryos, 3 
independent measurements were made at 30-second time intervals. All the measurements 
were performed by one investigator in the same order; the egg was placed on the 
thermoelement under the dissecting microscope, the Doppler probe was positioned and the 
recording was made. In between the measurements the egg was removed from its position. 
The exact time interval between the measurements was documented. The mean coefficient of 
variation (C.V., %) for heart rate, peak systolic velocity and time-averaged velocity was 
calculated to determine the intraobserver reproducibility. In the calculations, the C.V. was 
adjusted for the trend due to cooling over the time points by performing an analysis of 
P A 
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variance. A common linear trend was assumed for each embryo in this analysis. The resulting 
S.D. of residuals was taken as the S.D. of measurement error. All calculations and statistical 
analyses were performed with SPSS 10.1 software (SPSS Inc, Chicago, IL, USA). 
The mean coefficient of variation for heart rate (bpm), peak systolic velocity (PSV, mm/s) 
and time-averaged velocity (TAV, mm/s) was: 0.9% (range 0.8-1.0); 3.7% (range 2.8-4.9) and 
4.6% (range 3.0-7.0), respectively.  This indicates satisfactory intraobserver reproducibility 
for dorsal aortic waveform derived parameters.  
 
2.3 Servo-null pressure system 
Intraventricular pressure  
Blood pressure was measured in the ventricle (Fig.6+7) using a servo-null system (model 
900A, World Precision Instruments, Inc., Sarasota, Florida, USA) and a fluid filled (2M 
NaCl) 5-10µm glass micropipette attached to a microelectrode. Intraventricular pressure was 
calculated as the difference between the measured pressure and the pressure recorded when 
the tip of the pipette was placed in the extra-embryonic fluid adjacent to the ventricular 
puncture site  
The working principle of the servo-null method is described in detail by Heineman & 
Grayson 3, and Chabert & Taber 4, and can be summarized as follows: A 1 mm glass 
capillary, with one end drawn to typically 6µm inner diameter, is placed in a small 
microelectrode. This microelectrode is mounted on a micromanipulator, which is used to 
insert the pipette tip into the embryonic heart. The microelectrode and capillary are fluid-
filled with a highly conductive solution of 2M NaCl. The air on top of the fluid in the 
microelectrode is connected via a short flexible tube to the pressure pod, a small box near the 
microelectrode, in which the air pressure is measured continuously by a relatively fast 
responding pressure transducer. The pod pressure depends on the imbalance between air 
entering the pod from a pressure source through an electronically controlled valve, and air 
leaving the pod towards a vacuum sink. 
Via an electrode connected to the embryo, the electric resistance between blood plasma and 
conducting solution in the pipette and microelectrode is monitored continuously. At a steady 
plasma pressure, a constant resistance is obtained, which is caused by the relatively low ion 
concentration of the blood plasma inside the narrow pipette tip. On a rising blood pressure, 
the ion concentration gradient is forced into the pipette, thereby increasing the electric 
resistance. The differential resistance is amplified by a factor S, ‘sensitivity’ and fed into the 
controlled valve of the pressure pod, thereby increasing the airflow into the pod. As a result, 
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the microelectrode pressure increases and forces the ion concentration gradient back to its 
equilibrium position. To avoid oscillation of this system at a resonance frequency, the feed 
back loop is stabilized by mixing the signal that reaches the valve with the measured pressure 
signal multiplied by a factor D, ‘damping’. By this method, a stable system can be obtained, 
where the static pressure is measured accurately.  
 
 
 
 
Figure 6. 
Intraventricular pressure. 
Ventricle and outflow tract of a stage 
21 chick embryo. The pressure is 
measured inside the ventricular cavity 
using a glass micropipette. 
 
Figure 7.  Pressure signal.  
The measured pressure signal is presented with the 
corresponding pictures of the ventricle 
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Frequency response of servo-null system 
To establish the systems response to pressure oscillations in the blood, we tested the dynamic 
response of the system in vitro over the frequency range of 0.5-20Hz (as this frequency range 
is relevant to chick embryonic heart rate) by applying air pressure fluctuations on top of a 
liquid bath, in which the microelectrode with micropipette was inserted. The actual pressure 
was measured simultaneously, using a pressure transducer of known flat response up to 
130Hz (Setra Systems, Inc., Boxborough, MA, USA). The servo-null system was adjusted to 
various settings with respect to ‘sensitivity’ and ‘damping’.  
The dynamic response of the servo-null system relative to the actual pressure is shown in 
figure 8. We conclude that at the HR frequency (2-3Hz) the signal amplitude is amplified 
(under damped) by about 1% only and the phase delay is about 5-6 degrees, or 7ms, or about 
¼ of the frame time interval. For the 4th harmonic (10Hz)(at 4 times the HR frequency), 
where still 2-3% of the signal energy is present in the energy spectrum, the signal amplitude is 
amplified by about 20% and the phase delay is 25-30 degrees, or 8ms, or about ¼ of the frame 
time interval. We therefore conclude that the pressure is measured with sufficient accuracy. 
 
 
 
Figure  8. Dynamic frequency response curves of servo-null system.  
The left panel demonstrates the amplitude transfer curve of the measured pressure signal over a 
frequency range of 0.5 to 20 Hz relative to the actual pressure. The right panel demonstrates the 
phase delay curve of the signal. 
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2.4 Intraventricular volume  
During the pressure measurements the ventricle was visualised using video imaging with a 
stereo microscope (model SV 6, Carl Zeiss, Oberkochen, Germany) and a video camera 
(model SSC-M370CE, Sony Corporation, Tokyo, Japan). The video images were acquired 
simultaneously with the analog pressure signal at 50Hz and stored on a PC. Epicardial surface 
area was calculated from magnified video images displaying the ventricle using a custom-
built analysis program (IMAQ Vision, National Instruments, Austin, TX, USA)(Fig.9). 
Ventricular volume (V) was derived from epicardial area (A) using a simplified ellipsoid 
geometric model: V=0.65A3/2 as described by Keller et al 5.  
For each embryo 2-4 consecutive (baseline) cardiac cycles were analyzed.  Furthermore, to 
evaluate ventricular response to reduced venous return, a fourth order vitelline vein was 
incised to produce venous hemorrhage, which results in acute preload reduction. The cardiac 
cycles following hemorrhage were also recorded and subsequently analyzed to derive 
ventricular pressure-volume relations. By the latter procedure information can be obtained 
about ventricular contractility (through the end-systolic pressure volume relation) and 
diastolic stiffness (through the end-diastolic pressure volume relation). 
Finally, maximum contraction of the heart with 2M NaCl was induced for determination of 
ventricular wall volume by video imaging (Fig.9). The solution (1-3µl) was applied directly 
on the ventricle. Cavity volume was calculated as total volume minus wall volume.  
 
Figure 9. 
The ventricle is traced to obtain the surface area, from which ventricular volume is calculated. At the 
end of the experiment 2 molar NaCl is applicated onto the ventricle to achieve maximum ventricular 
contraction, and ventricular wall volume is calculated. After subtraction of ventricular wall volume 
from all the obtained volumes during the cardiac cycle the ventricular blood volumes are obtained, 
which are used to create pressure-volume relations.  
1mm 
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We validated this method in a set of four embryos at stage 21 in which wall volume obtained 
by video imaging was compared with wall volume obtained by the counting method of 
Cavalieri, detailed by Gundersen and Jensen 6. The wall volume of the ventricles was 
determined by video imaging after 2M NaCl application, directly followed by fixation with 
4% paraformaldehyde in 0.1M phosphate buffer. The hearts were embedded in paraffin, 
serially sectioned at 5-µm thickness, and stained with hematoxylin-eosin for stereologic 
examination. The number of points on a grid hitting 15 sections of the ventricle was counted. 
The first section was taken randomly and the other sections were taken systematically. From 
the counted numbers, the volumes could be calculated by Cavalieri’s formula:   
V = Σ P . M -2 . a . d, where V is the volume in mm3 , Σ P  is the total number of counted 
points on the 15 sections, M the magnification, a is the point area in mm2 , and d is the 
distance between the counted sections in mm. 
The mean ventricular wall volume obtained by video imaging was 0.171 ± 0.009µl and mean 
myocardial wall volume obtained by Cavalieri’s method was 0.157 ± 0.010µl, which means 
that ventricular wall volume is overestimated by 8.9%. Therefore, we concluded that the 
video imaging procedure correlates well with stereologically obtained volumes and we chose 
not to correct for this overestimation in the calculations. 
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2.5 Assessment of ventricular function  
By combining pressure and volume data, pressure-volume loops are obtained (Fig.10). 
Figure 10. 
Panels A and B show an intraventricular pressure signal with the corresponding volumes. In panel C 
these data are combined into pressure-volume loops.  
 
Pressure-volume loops give information about ventricular function. A large number of 
parameters can be determined using pressure-volume loop analysis. Figure 11 demonstrates 
some basic principles of this analysis.  
Figure 11. Pressure-volume loop analysis.  At 
point A the atrioventricular cushions open and 
blood flows from the atrium into the ventricle 
during diastole. At point B the maximum volume 
is reached and the cushions close. Isovolumic 
contraction causes an increase in pressure up to 
point C, where the outflow tract cushions open 
and blood flows from the ventricle into the aorta 
during systole. At point D the outflow tract 
cushions close and isovolumic relaxation occurs 
back to point A. These steps are followed each cardiac cycle. The end-systolic pressure-volume 
relation (ESPVR) and the end-diastolic pressure-volume relation (EDPVR) are determined by the end-
systolic points (D and D’) and the end-diastolic points (B and B’) of the baseline pressure-volume loop 
(black loop) and loop after preload reduction (grey loop). Stroke volume (SV) can also be obtained 
from the baseline loop. 
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From the baseline loops (black loop) the following parameters can be obtained: end-systolic 
and end-diastolic pressures and volumes (ESP, EDP, (mmHg); ESV, EDV, (µl)) and stroke 
volume (SV, µl) as the difference between EDV and ESV. Cardiac output (CO, µl/min) as HR 
multiplied by SV, ejection fraction (EF, %) as SV divided by EDV and stroke work (SW, 
(µl⋅mmHg) as the area of the pressure-volume loop. The latter three are ejection phase, 
afterload-dependent indices of systolic performance. 
When preload is lowered the pressure-volume loops will shift downwards to the left (grey 
loop). This allows determination of the end-systolic and end-diastolic pressure-volume 
relationships as load-independent measures of systolic and diastolic ventricular function. The 
end-systolic pressure-volume relationship (ESPVR) is determined by the end-systolic points. 
The slope of this relation (EES, (mmHg/µl)) is a measure for ventricular contractility. The end-
diastolic pressure-volume relationship (EDPVR) is determined by the end-diastolic points and 
reflects the passive properties of the ventricle. The slope of this relation (EED (mmHg/µl)) is a 
measure for diastolic ventricular stiffness.  
Furthermore, from the pressure and volume data the following parameters can also be 
calculated: the maximum and minimum first derivatives of pressure (dP/dtMAX, dP/dtMIN, 
mmHg/s). dP/dtMAX is an index of contractility from the isovolumic contraction phase that is 
afterload independent, however sensitive to change in preload. Peak filling rate (PFR, µl/s) 
represents the maximum first derivative of ventricular volume with respect to time (dV/dt), 
peak ejection rate (PER, µl/s) represents the minimum first derivative of ventricular volume 
with respect to time (dV/dt), and the relaxation time constant Tau (τ, ms) represents the time-
constant of mono-exponential pressure decay during isovolumic relaxation (Fig.12). The 
isovolumic period is defined as the time-period between the moment of dP/dtMIN and the time-
point at which dP/dt reached 10% of dP/dtMIN 7. The relaxation time constant Tau (τ), an 
index of active (isovolumic) relaxation, can be calculated as the time-constant of mono-
exponential pressure decay during isovolumic relaxation using P=A+B.exp(-t/tau), in which A 
and B are constants determined by the data 8. In addition pressure-half-time (PHT, ms) can be 
determined as the time-interval between the moment of dP/dtMIN and the moment that 
pressure has dropped to 50% of the instantaneous pressure at the moment of dP/dtMIN. 
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Figure 12. 
This figure demonstrates how dP/dtMIN, the relaxation time constant Tau and PHT are determined. The 
isovolumic period starts at the time-point of dP/dtMIN and ends at the time-point at which dP/dt reaches 
10% of dP/dtMIN. PHT is calculated as the time-interval between the moment of dP/dtMIN and the 
moment that pressure has dropped to 50% of the instantaneous pressure at the moment of dP/dtMIN. 
 
These parameters are a measure of different determinants of ventricular function. The use of 
this method during early embryonic development could improve our understanding of the 
intricate relationship between cardiac morphogenesis and cardiac function. 
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Chapter 3 
Acute hemodynamic effects 
of venous clipping in the 
chick embryo 
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Introductory remarks 
In the venous clip model cardiovascular malformations are induced by extra-embryonic 
venous obstruction. Previous studies using India ink injections clearly demonstrated that the 
venous clip procedure at HH17 leads to changes in blood flow patterns through the heart. 
These changes probably also affect hemodynamics. This chapter describes the direct influence 
of the venous clip procedure on hemodynamic parameters as assessed by Doppler blood flow 
velocimetry. Altered shear stress responsive gene expression could be the link between 
hemodynamic disturbances and the observed malformations.  
 
3.1 Acutely altered hemodynamics following venous obstruction in the early chick 
embryo 
Journal of Experimental Biology 2003; 206:1051-1057 (adapted for this thesis) 
 
Summary 
In the venous clip model specific cardiac malformations are induced in the chick embryo by 
obstructing the right lateral vitelline vein with a microclip. Clipping alters venous return and 
intracardiac laminar blood flow patterns, with secondary effects on the mechanical load of the 
embryonic myocardium. We investigated the instantaneous effects of clipping the right lateral 
vitelline vein on hemodynamics in the stage-17 chick embryo. Thirty-two chick embryos HH 
17 were subdivided into venous clipped (N=16) and matched control embryos (N=16). Dorsal 
aortic blood flow velocity was measured with a 20 MHz pulsed Doppler meter. A time series 
of eight successive measurements per embryo was made starting just before clipping and 
ending 5 h after clipping. Heart rate, peak systolic velocity, time-averaged velocity, peak 
blood flow, mean blood flow, peak acceleration and stroke volume were determined. All 
hemodynamic parameters decreased acutely after venous clipping and only three out of seven 
parameters (heart rate, time-averaged velocity and mean blood flow) showed a recovery to 
baseline values during the 5 h study period. We conclude that the experimental alteration of 
venous return has major acute effects on hemodynamics in the chick embryo. These effects 
may be responsible for the observed cardiac malformations after clipping. 
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Introduction 
The earliest stage at which the beating embryonic human heart can be visualised is the sixth 
week of gestation, using ultrasonography. Detailed analysis of fetal cardiac and extracardiac 
flow velocity waveforms using combined high-resolution, 2-dimensional ultrasound and 
Doppler techniques is possible after 8 to 9 weeks onward 1. The most essential events in 
human cardiovascular development, however, take place between 3-8 weeks of gestation, 
during which the embryonic heart develops from a muscle wrapped tube into the septated 
four-chambered heart, so animal models are required to study mechanisms of early 
cardiovascular development.  
The chick embryo has been used as a model for many decades because in many aspects the 
embryonic chick heart resembles the developing human heart 2,3. An intervention model for 
the chick embryo was designed to obtain insight into the long-term hemodynamic effects of 
altered venous return patterns on cardiac morphogenesis and malformations. Specific cardiac 
malformations were induced by permanently obstructing the right lateral vitelline vein with a 
microclip, (venous clip model 4) thereby altering the intracardiac blood flow patterns. A 
spectrum of outflow tract anomalies can be induced by this intervention. Hogers et al. 4 
postulated that alterations in hemodynamic parameters could lead to changes in shear stress, 
which could alter the expression of shear stress responsive genes with downstream alterations 
in developmental processes resulting in cardiac malformations. The observation of 
intracardiac blood flow pattern alterations during clipping, visualised by injected India ink, 
suggested that hemodynamics is influenced by clipping 5. Other studies have also shown that 
alterations in hemodynamics can precede the onset of structural defects 6.  
A previous study from our group has demonstrated that at stage 34 (day 8 of incubation) heart 
rate was decreased in embryos that had been clipped at stage 17 (stages according to 
Hamburger and Hamilton, 1951), whereas peak systolic and mean systolic velocities, as well 
as peak and mean blood flow were increased compared to normal embryos 7,8. These results 
showed the presence of long term hemodynamic changes after clipping. However, at this 
point (stage 34) cardiac malformations are already present, so it is impossible to discriminate 
between the effects of cardiac malformations and any direct effects of clipping on 
hemodynamics.  
By a modification of the method used for Doppler frequency detection it is now possible to 
obtain good quality waveforms directly after clipping at stage 17 9. This allows examination 
of the direct effects of clipping on hemodynamics, to improve our understanding of how 
cardiac anomalies may arise following venous obstruction. We hypothesise that cardiac 
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malformations induced by clipping are caused by instantaneous changes in blood flow 
through the heart resulting in altered activation of shear stress responsive genes. In the present 
work we show the instantaneous effects of clipping the right lateral vitelline vein on 
hemodynamics in the stage 17 (52-64 h of incubation) chick embryo.    
 
Materials and Methods  
Animals 
Fertilized white Leghorn chick eggs Gallus domesticus L. were obtained from Charles River 
Laboratories (Extertal, Germany) and were incubated at 37-38°C, with the blunt end up and at 
a relative humidity of 70-80%. The embryos were exposed by creating a window in the shell 
and removing the overlying membranes. Only embryos that were at Hamburger and Hamilton 
stage 17 (HH17) 7 and that showed no bleeding or deformities were selected. A total of 32 
embryos was included. The material was subdivided into venous clipped (n=16) embryos and 
control embryos (n=16). In the clipped group the vitelline membrane was removed adjacent to 
the right vitelline vein and a small incision in the yolk sac membrane was made. 
Subsequently, the right vitelline vein was obstructed with an aluminum microclip (Fig. 1). 
Cessation of blood flow proximal to the microclip was confirmed under microscopic 
surveillance. The microclips were made of a 0.2mm aluminum sheet. All experiments were 
performed in ovo. During the experiments the egg was placed on a thermoelement of 37°C. In 
between measurements the window in the shell was resealed with tape and the egg was 
reincubated.  
 
 
 
 
Figure 1. Stage 17 chick embryo with an 
aluminium microclip (mc) positioned at the 
right lateral vitelline vein (rlvv), causing 
cessation of blood flow proximal to the 
microclip. heart (h), dorsal aorta (da). Scale 
bar is 1 mm.
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Hemodynamics in the chick embryo  
The chick embryo has been used as a model to study hemodynamics and cardiovascular 
development for many decades. Chick embryonic development is completed in 21 days. 
Hamburger and Hamilton divided this period into 46 developmental stages based on 
morphological landmarks 7. Using this classification system the developmental age of each 
embryo can be established accurately. 
The heart is the first organ that forms and functions in the embryo. At HH10 (33-38hrs) the 
first heartbeat is detected and at HH12 (45-49hrs) blood flow is present. The heart is 
responsible for pumping blood to the embryo and the extra-embryonic circulation that 
provides the embryo with oxygen and nutrients and removes waste products. This means that 
its function is already crucial during the process in which the heart is transformed from a 
muscle wrapped tube into a 4-chambered septated heart. Thus forces generated by cardiac 
contraction and relaxation, for instance blood pressure and blood flow, likely influence 
cardiovascular development 10.   
The embryo grows rapidly. Embryonic weight increases 100-fold between HH12 and HH29 
from 2.22mg to 267.5mg and ventricular weight show a 30-fold increase from 0.1 to 3.18mg 
10. Dorsal aortic blood flow increases parallel with embryonic growth 10 and the relative 
weight of the ventricle decreases 11. This suggests that somehow cardiac output and metabolic 
demands are coupled precisely and that the cardiovascular system is increasingly effective. 
Blood pressure waveforms are strikingly similar to those in mature circulations. The atrial 
pressure curve has a distinct A-wave. The ventricular pressure curve has a characteristic early 
diastolic passive rise and late diastolic active atrial accentuation 10. Ventricular systole has an 
isovolumic contraction phase, ejection phase and isovolumic relaxation phase. The arterial 
pressure waveform shows distinct diastolic and systolic pressures, including a dicrotic notch 
10. 
Cardiac function in the embryo and adult animal is determined by preload, afterload, heart 
rate and myocardial contractility. Preload depends on the diastolic phase, in which the 
ventricle is filled with blood. Diastole can be partitioned into a passive filling component and 
an active filling component. During the passive phase blood flows from the atrium to the 
ventricle due to the pressure-gradient 12. Hereafter, active filling is established by atrial 
contraction. During development the ratio of passive to active filling volume decreases 
because the active filling increases geometrically 13. The atrioventricular flow pattern may be 
a mechanical-biologic link to ventricular chamber growth and a determination of ventricular 
chamber volume 13. Cardiac output depends on preload. In early stages of development the 
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neurohumoral and autonomic nervous systems are not present yet and cardiac output is 
controlled by the Frank-Starling mechanism 14. Wagman et al. demonstrated the presence of 
this mechanism in the chick embryo by volume injections that lead to increased dorsal aortic 
blood velocity and stroke volume. 
Afterload, the force against which the ventricle contracts, decreases during development as 
the vascular bed grows rapidly 2. Vascular resistance may be also controlled by receptor-
mediated changes in vascular tone. Injections with ß-adrenergic agonists resulted in increased 
vascular resistance 15. Atrial natriuretic peptide (ANP) causes vasodilatation and a decrease in 
passive filling resulting in decreased preload and cardiac output 16,17.  
Heart rate increases from about 103 bpm at HH12 to more than 239 bpm at the time the 
embryo hatches 10,18. Heart rate influences filling characteristics of the ventricle. Experimental 
pacing faster than intrinsic heart rate leads to a decrease in stroke volume, due to a reduction 
in passive filling 19, which can be reversed by volume loading during pacing 20. This is again 
probably the result of the Frank-Starling principle. Environmental factors like temperature 
also influences cardiac function profoundly 21,22. An increase in temperature results in an 
increase in heart rate, cardiac output and a decrease in vascular resistance, while a decrease in 
temperature results in opposite effects. Stroke volume seems not to be influenced, as it 
remains constant during temperature changes.  
Pump performance increases with development, which is probably due to better organization 
and a more orderly arrangement of the myofibrils leading to increased myocardial 
contractility 23.  Also maturation in the calcium transport system 24 and  
Functional changes in hemodynamics occur prior to any observable abnormal structural 
changes in heart or aortic arch arteries of embryos with cardiac neural crest ablations 6. 
Embryos with neural crest ablations had significantly greater dorsal aortic blood flow velocity 
and lower systolic and diastolic blood pressures than controls. It is likely that blood pressure 
and blood flow are important determinants for development of the heart and vessels and that 
the final organization of the myocardium is in part determined by hemodynamic forces 
interacting with the developing ventricular walls 23. Knowledge of developmental 
mechanisms is the key to understanding the link between etiologic factors and cardiac 
malformations 25. 
 
Measurements 
Eight dorsal aortic blood flow velocity measurements were made per embryo. The first 
velocity measurement (baseline) was done directly after exposure of the embryo. The second 
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measurement was performed directly after successful clipping of the right vitelline vein at 
approximately four min from the first measurement. For each clipped embryo a control 
embryo was measured, matched for the exact time interval between the first measurement 
before clipping and the second measurement directly after clipping. This was important since 
cooling of the embryo would take place despite the use of a thermoelement, and cooling of the 
embryo influences the outcome of the measurements 21,26. The third measurement was 
performed 30 min after clipping, the fourth to eighth recordings occurred at 1, 2, 3, 4 and 5 h 
after clipping, respectively. The control embryos were subjected to the same measurement 
schedule as venous clipped embryos. 
 
Materials 
Dorsal aortic blood flow velocity was measured using a 20-MHz pulsed Doppler meter 
(model 545C-4, Iowa Doppler Products, Iowa City, IA, USA). The Doppler audio signals 
were digitized at 12 kHz and stored on hard disk. Using complex fast Fourier transform 
analysis, the maximum velocity waveform was reconstructed. A more detailed description of 
this method has been published previously 9. The Doppler probe consisting of a 750µm 
piezoelectric crystal was positioned at a 45º angle to the dorsal aorta at the level of the 
developing wing bud. The sample volume was adjusted to cover the lumen of the dorsal aorta 
only, excluding other adjacent vessels. The internal aortic diameter was measured at the same 
level by video imaging using a stereo microscope (model SV 6, Carl Zeiss, Oberkochen, 
Germany) and a video camera (model SSC-M370CE, Sony Corporation, Tokyo, Japan). The 
video images were acquired with an image acquisition board (IMAQ PCI-1408, National 
Instruments, Austin, TX, USA) and subsequently analyzed using a custom-built analysis 
program using IMAQ Vision software (National Instruments). Size calibration in the 
horizontal and vertical planes of the image was performed by videotaping a scale divided into 
10µm divisions. Aortic diameter was calculated by incorporating the magnified video image 
displaying the dorsal aorta into the image analysis program.  
Blood flow Q was calculated from Q=vπd2/4, where v is mean aortic blood flow velocity and 
d is the internal aortic diameter. Peak acceleration (dv/dt) was derived from the dorsal aortic 
blood flow velocity by means of digital differentiation. Stroke volume was determined from 
the quotient of the dorsal aortic blood flow and the heart rate. We determined peak systolic 
velocity (PSV, mm/s), time-averaged velocity (TAV, mm/s), heart rate (bpm), peak blood 
flow (mm3/s), mean blood flow (mm3/s), peak acceleration (mm/s2) and stroke volume (mm3) 
for each cardiac cycle. For each embryo a high quality waveform recording of 10 seconds was 
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used for the analysis. The 10-second recordings contain 20-27 heartbeats. For all 
hemodynamic parameters in each embryo, the average of all cardiac cycles was calculated.  
Statistical analysis  
Heart rate, PSV, TAV, peak blood flow, mean blood flow, peak acceleration and stroke 
volume data are presented as mean ± standard error of the mean (S.E.M.). Hemodynamic 
parameters were compared within and between groups. Paired t-tests were performed within 
each group to compare mean values at all time points with baseline values. Repeated 
measurements ANOVA, using SAS PROC MIXED, was performed on the net changes from 
baseline level to assess whether the profiles of the net changes paralleled each other. The 
values were standardized by taking the net changes from baseline level in order to adjust for 
biological variability. Net change profiles in a parallel position indicated a significant 
difference in the net changes throughout the 5-h study period between the clipped and control 
group. If the profiles differed significantly from parallelism, paired t-tests were performed at 
each time point to compare both groups.  P< 0.05 was considered statistically significant. 
Statistical analyses were performed using SPSS 10.1 software and SAS 6.12 software (SAS 
Institute Inc, Cary, NC, USA).  
 
Results 
The means ± S.E.M. of all the measured parameters in the clipped embryos (n=16) and 
control embryos (n=16) at all time points are presented in table 1. The baseline values of all 
parameters did not significantly differ between both groups. The mean time required to place 
the microclip was 4 min (range 3.23-4.15), and the control group was matched for this 4 min 
period to differentiate between the influence of cooling of the embryo and clipping. All 
hemodynamic parameters decreased markedly during the venous clip procedure in the clipped 
group and the 4 min period in the control group.  
The profiles of changes from baseline level of all the parameters did not significantly differ 
from parallelism (P>0.05), except for heart rate and peak acceleration (P<0.05).  
Directly after clipping or the 4 min period (controls), heart rate decreased significantly in both 
groups (Fig. 2A). This decrease was not significantly different between the groups. However, 
at 30 min, 1 and 2 h the difference in heart rate between the clipped and control group was 
significant. In the clipped group it took 3 h for the heart rate to gradually return to baseline 
level, whereas the control group showed a recovery within 30 min.  
The profile of the net changes in the PSV of the clipped group (Fig. 2B) was significantly 
below the profile of the control group (P<0.001). The clipped group demonstrated a 57% 
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decrease of PSV after clipping as compared with a 19% decrease in the control group. This 
decrease stabilized at 30 min after clipping at ± 22%. In the control group PSV was 
significantly elevated at all time points beyond 2 h compared to baseline level. 
The profile of the net changes in TAV of the clipped group (Fig. 2C) was significantly lower 
than the profile of the control group (P<0.001). Following an initially significant decrease of 
53% in the clipped group, TAV slowly stabilized at a level of 17% below baseline level. The 
control group recovered within 30 min and showed a significantly raised TAV at 4 and 5 h. 
The profile of the net changes in peak blood flow of the clipped group (Fig. 2D) was 
significantly below the profile of the control group (P<0.001). Peak blood flow decreased by 
58% directly after clipping as compared with 18% in the control group. This decrease in the 
clipped group stabilized significantly below the baseline level at 30 min after clipping. The 
control group displayed a significantly elevated peak blood flow after 3 h. 
The profile of the net changes in mean blood flow of the clipped group (Fig. 2E) was 
significantly below the profile of the control group (P<0.001). In the clipped group mean 
blood flow was significantly lower directly after clipping, at 30 min and at 1 h after clipping 
as compared with baseline level. No significant differences existed at later time points. The 
control group only showed a significant decrease after the 4-min period and even 
demonstrated a significantly elevated level of mean blood flow at 4 and 5 h. 
The profiles of net changes in peak acceleration (Fig. 2F) significantly (P<0.05) deviated 
from parallelism. The net changes in peak acceleration of the clipped group and the control 
group were significantly different at all time points. Within the clipped group peak 
acceleration was significantly decreased at all time points after clipping as compared with 
baseline level. The control group showed a significant decrease after the 4-min period only 
and a significant increase at all time points thereafter. 
The profile of the net changes in stroke volume of the clipped group (Fig. 2G) was 
significantly lower than the profile of the control group (P<0.001). Stroke volume was 
significantly lower up to 1 h after clipping. At 4 and 5 h stroke volume was also significantly 
reduced. The control group demonstrated a significant decrease only immediately after the 4-
min period. 
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Figure 2. Effects of clipping the right lateral 
vitelline vein on hemodynamic parameters in the 
stage-17 chick embryo. (A) Heart rate (bpm); 
(B) peak systolic velocity (mm/s); (C) time-
averaged velocity (mm/s); (D) peak blood flow 
(mm3/s); (E) mean blood flow (mm3/s); (F) peak 
acceleration (mm/s2); (G) stroke volume (mm3). 
Values of net changes from baseline level of all 
hemodynamic parameters at corresponding 
times (hr) are shown as means ± S.E.M. Solid 
circles, clipped group (N=16); open circles, 
control group (N=16). *P<0.05 for  
  the comparison with baseline values within groups. The profiles in B–E and G are in a parallel 
position to each other, which indicates a significant difference in the net changes from baseline level 
throughout the 5 h study period. The profiles in A and F do not run parallel to each other, therefore 
paired t-tests were performed for these parameters to compare values between both groups at the 
different measurement points, # P<0.05. 
A B 
C D 
E F 
G 
# ##
#
#
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Discussion 
This study describes the instantaneous effects of clipping the right lateral vitelline vein on 
hemodynamics in the stage 17-chick embryo. The objective was to obtain insight into the 
direct effects of clipping on hemodynamics using Doppler ultrasonography. Because of the 
intricate relationship between hemodynamics and morphogenesis, this could improve our 
understanding as to how cardiac anomalies arise following venous obstruction. In the venous 
clip model, extraembryonic blood flow is manipulated without direct mechanical interference 
of the heart such as occurs by altering neural crest migration to the arterial pole of the heart 27 
or of the cervical flexure 28. Clipping causes a detour of venous inflow to the heart, which 
alters the intracardiac blood flow patterns, as has been visualised with India ink injections, 
and induces specific cardiac malformations 4. After clipping, venous blood that is normally 
drained by the right lateral vitelline vein to the heart is redirected to the posterior vitelline 
vein via a small capillary vessel, which expands into a large anastomosis within a few hours. 
The alterations in intracardiac blood flow patterns observed immediately after clipping 
suggest that hemodynamics is influenced by clipping 5. The present study demonstrates that 
there are major hemodynamic changes during the first 5 h after clipping and we hypothesise 
about the consequences of these hemodynamic changes in relation to cardiac development.  
A significant reduction after clipping is demonstrated for all hemodynamic parameters with a 
recovery seen for only 3 out of 7 parameters (heart rate, time-averaged velocity and mean 
blood flow) during the 5-hour study period. In the control group all parameters recovered to 
baseline values and displayed an additional increase after 5 h, as could be expected in a 
normally developing embryo. It is likely that most if not all hemodynamic parameters in the 
clipped group will recover within the next stages of development, especially since 
Broekhuizen et al. 8 observed no significant differences in hemodynamic parameters at stage 
24 between clipped and control embryos except for a lower peak acceleration. 
In the clipped group it was evident that the magnitude of decrease of the hemodynamic 
parameters observed at the first measurement after clipping was mainly due to clipping, with 
additional effects due to cooling. In the control group the observed hemodynamic changes 
after the 4 min period were due to minor handling and due to cooling of the embryo.  It is 
known that chick embryo hemodynamics is greatly influenced by temperature 21,22,26. 
Prolonged incubation at low temperatures can even give rise to cardiac malformations 29. De 
la Cruz et al. 29 observed cardiac malformations in 18.8% of the embryos that had survived 
during continuous incubation at 35.8ºC until hatching. In the clip study by Hogers et al. 4 the 
clipped embryos were only subjected to cooling for approximately 4 min as were our 
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embryos. In their study specific cardiac malformations were induced in 64% of the clipped 
embryos, which is much higher than the 18.8% cardiac malformations observed by de la Cruz 
et al. 29 during continuous incubation at a low temperature. This supports the conclusion of 
Hogers et al. 4 that the cardiac malformations observed by them are caused by obstruction of 
the right lateral vitelline vein.  
When considering the first 30 min of the study period the clipped group was characterized by 
a significant drop in all hemodynamic parameters whereas in the control group there was a 
return to baseline level at 30 min. The clipped group also displayed a significantly larger 
decrease in each hemodynamic parameter as compared with the control group. The changes in 
the hemodynamic parameters during the first 30 min may be explained as follows. Blood, 
circulating in the segment of the yolk sac vascular bed that is normally drained by the right 
lateral vitelline vein, is blocked due to clipping and can therefore not return directly to the 
heart. Blood is captured in the vitelline vascular bed while the heart keeps on pumping blood 
into all segments of the vascular bed. Therefore, the actively circulating blood volume is 
decreased, which results in a drop in venous return or preload and subsequently cardiac stroke 
volume. The decrease in preload also results in a decrease in peak acceleration, reflecting 
cardiac contraction force.  
During the remainder of the study period, observations in the clipped group showed a full 
recovery for time-averaged velocity and mean blood flow 5 h after clipping. All other 
parameters demonstrated a partial recovery that however, remained significantly below 
baseline level. From these observations it can be assumed that the embryo compensates to 
maintain a steady blood supply to all organs. With the development of the vitelline vascular 
bed, vascular resistance and impedance decreases 10,14,30. Therefore, we postulate that when a 
part of the vitelline vascular bed is closed off from the rest of the vascular bed, the vascular 
resistance will rise. Even when the anastomosis is formed that permanently provides a detour 
of blood flow towards the heart, the venous vascular resistance will remain elevated because 
blood has to pass along a longer route to reach the heart. There is a new steady state in the 
hemodynamic situation that at least meets the demands of the embryo that are necessary to 
survive 5 h after clipping. When comparing the clipped and control group, all hemodynamic 
parameters of the latter are situated well above the baseline except for stroke volume. These 
findings probably reflect embryonic growth during the study period. As has been described by 
others, hemodynamic parameters increase with growth of the embryo 10,18.  
The effects of venous clip on heart rate are more complex. There is an initial drop in heart rate 
in both the clipped and control group at 4 min, which however is not significantly different 
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between the groups. This suggests a cooling effect rather than a clipping effect. As outlined 
above, clipping causes an acute decrease in preload. It is known that heart rate does not 
respond to acute alterations in loading conditions 31. However, at 30 min to 2 h after clipping 
heart rate remained significantly lower than in control embryos. This suggests a direct 
influence on the pacemaker function of the heart that prevents a quick and normal heart rate 
recovery. The cardiac autonomic nervous system is not functional until HH 41, which rules 
out any impact of this system on heart rate 32,33. Nevertheless, there is evidence of the 
presence of ß-adrenergic receptors in the myocardium at day 2-2.5 of incubation and 
circulating neurohumoral agents 34. The sudden and persistent decrease in preload following 
clipping may trigger a release of neurohumoral agents or a change in sensitivity for these 
agents resulting in a temporary decrease in heart rate. 
The question arises as to how these hemodynamic changes relate to the development of 
cardiac malformations. During normal cardiac development, cardiac performance increases 
2,23 and results in gradual changes in shear stress that either up- or downregulate the 
expression of shear stress responsive genes 35,36 . In vitro studies have demonstrated that 
endothelial cells are subjected to fluid shear stress as a result of blood flow and are aligned in 
the direction of the flow 36,37 and that especially changes in shear stress cause alterations in 
gene expression 38. Shear stress depends directly on volume flow 39. When major alterations 
occur in one of the hemodynamic parameters that directly influence the shear stress, it seems 
feasible that altered expression of shear stress responsive genes with secondary effects on 
cardiac development can be expected. Other studies have also shown that alterations in 
hemodynamics can precede the onset of structural defects 6. The marked decrease in mean 
blood flow observed in this study may lead to an acute decrease in shear stress, which could 
be responsible for the induction of cardiac malformations by altering shear stress responsive 
gene expression.  
  
In summary we conclude that obstruction of the right lateral vitelline vein results in major 
hemodynamic changes during the first 5 h after clipping. We suggest that these hemodynamic 
changes induce cardiovascular malformations by altering normal patterns of shear stress 
responsive gene expression.  
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Chapter 4 
Pressure-Volume loop 
analysis after venous clipping 
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Introductory remarks 
Cardiac pressure-volume loop analysis enables determination of end-systolic elastance and 
end-diastolic stiffness of the developing ventricle. These parameters represent intrinsic 
myocardial properties and are relatively independent of loading conditions. We tested the 
hypothesis that venous clipping could lead to long-term changes in ventricular function. We 
performed pressure-volume loop analysis of the embryonic chick heart at stage 21 and stage 
24, respectively one day and two days after the venous clip procedure. The use of this method 
in early stages of development could contribute to a better understanding of the relationship 
between cardiac function and morphogenesis during normal and abnormal cardiac 
development. In this chapter the impact of early venous obstruction on embryonic 
cardiovascular function in later development is presented.  
 
4.1 Systolic and diastolic ventricular function assessed by pressure-volume loops in 
the stage 21 venous clipped chick embryo 
Pediatric Research 2005;57(1):16-21. 
 
Summary 
Cardiac pressure-volume relations enable quantification of intrinsic ventricular diastolic and 
systolic properties independent of loading conditions. The use of pressure-volume loop 
analysis in early stages of development could contribute to a better understanding of the 
relationship between hemodynamics and cardiac morphogenesis. The venous clip model is an 
intervention model for the chick embryo, in which permanent obstruction of the right lateral 
vitelline vein temporarily reduces the mechanical load on the embryonic myocardium and 
induces a spectrum of outflow tract anomalies.  
We used pressure-volume loop analysis of the embryonic chick heart at stage 21 (3.5 days of 
incubation) in order to investigate whether the development of ventricular function is affected 
by venous clipping at stage 17, as compared to normal control embryos. 
Steady state hemodynamic parameters demonstrated no significant differences between the 
venous clipped and control embryos. However analysis of pressure-volume relations showed 
a significantly lower end-systolic elastance in the clipped embryos (EES, slope of the end-
systolic pressure-volume relation: 5.68±0.85 vs. 11.76±2.70mmHg/µl, p<0.05) indicating 
reduced contractility. Diastolic stiffness tended to be increased in the clipped embryos (EED, 
                                                                  55
slope of end-diastolic pressure-volume relation: 2.74±0.56 vs. 1.67±0.21, p=0.103) but the 
difference did not reach statistical significance. 
The results of the pressure-volume loop analysis show that one day after venous obstruction, 
development of ventricular function is affected, with reduced contractility. Pressure-volume 
analysis may be applied in the chick embryo and is a sensitive technique to detect subtle 
alterations in ventricular function. 
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Introduction 
Animal models are required to study mechanisms of early cardiovascular development. The 
chick embryo has been used as a model for many decades because the embryonic chick heart 
resembles the developing human heart in many aspects 1,2. Especially the intricate relationship 
between hemodynamics and cardiac morphogenesis has been a major study topic in this 
model.  
The venous clip model is an intervention model for the chick embryo, in which permanent 
obstruction of the right lateral vitelline vein temporarily reduces the mechanical load on the 
embryonic myocardium and induces a spectrum of outflow tract anomalies 3. This model was 
designed to obtain insight into the effects of altered venous return patterns on cardiac 
morphogenesis and malformations 4.  
In the chick embryo, information on cardiac function can be assessed through blood flow 
velocities and pressure waveform recordings 1,5-7. In a previous study using a 20MHz Doppler 
velocity meter, we have demonstrated that the experimental alteration of venous return caused 
by venous clipping has major acute effects on hemodynamics in the HH (Hamburger and 
Hamilton) stage 17 chick embryo 3,8. Peak systolic velocity, peak blood flow, and stroke 
volume are all significantly decreased for up to 5 hours after clipping. However, dorsal aortic 
Doppler measurements give indirect information on cardiac function. Direct information can 
be assessed using cardiac pressure-volume loop analysis 9. This method enables assessment of 
ventricular diastolic and systolic properties independent of loading conditions. Pressure-
volume analysis has been widely used in both human and animal studies 10-12. Only a few 
studies have been done during embryonic or fetal development; in (near term) fetal lambs and 
chick embryos 9,13-15. 
The use of pressure-volume loop analysis in early stages of development could contribute to a 
better understanding of cardiovascular developmental processes and especially the 
relationship between cardiac function and cardiac morphogenesis as cardiac morphogenesis 
depends on the interaction between genetics and epigenetic influences like fluid mechanical 
forces 16.  
Since mechanical load influences cardiac development and clipping the right lateral vitelline 
vein alters mechanical load we tested the hypothesis that clipping could lead to long-term 
changes in ventricular function. For this purpose a custom-made workstation was used to 
simultaneously measure intraventricular pressure and capture video images of the beating 
ventricle. We performed pressure-volume loop analysis of the embryonic chick heart at stage 
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21 in order to investigate whether the development of ventricular function is affected by 
venous clipping at stage 17 as compared to normal control embryos. 
 
Materials and Methods 
Animals 
Fertilized white Leghorn chick eggs (Gallus gallus (L.)) were obtained from Charles River 
Laboratories (Extertal, Germany) and were incubated at 37-38°C, with the blunt end up and at 
a relative humidity of 70-80%. The embryos were exposed by creating a window in the shell 
and removing the overlying membranes. Twenty-one embryos that were at HH stage 17 and 
that showed no bleeding or deformities were selected 8. The material was subdivided into 
venous clipped embryos (n=11), in which the right vitelline vein was obstructed with an 
aluminum microclip, and control embryos (n=10). A more detailed description of the clipping 
procedure has been published previously 3. During the experiments the egg was placed on a 
thermoelement of 37°C. Experiments were approved by the Animal Experimentation Review 
Board of the Erasmus MC and were performed in accordance with Dutch Law for animal 
experimentation 
 
Intraventricular pressure  
Blood pressure was measured in the ventricle at HH stage 21 (Fig.1) using a servo-null 
system (model 900A, World Precision Instruments, Inc., Sarasota, Florida, USA) and a fluid 
filled (2M NaCl) 5-10µm glass micropipette attached to a microelectrode.  
 
 
Figure 1. Stage 21-chick embryo (3.5 days of 
incubation). 
 
 
 
 
 
 
 
Intraventricular pressure was calculated as the difference between the measured pressure and 
the pressure recorded when the tip of the pipette was placed in the extra-embryonic fluid 
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adjacent to the ventricular puncture site. Pressure data were sampled at 50Hz and stored on a 
PC. The working principle of this pressure transducer is described in detail by Heineman 17. 
The dynamic response of the system was tested over the frequency range of 0.5-20Hz (as this 
frequency range is relevant to chicken embryonic heart rate) by applying air pressure 
fluctuations on top of a liquid bath in which the probe with micropipette was inserted. The 
actual pressure was measured simultaneously, using a pressure transducer of known flat 
response up to 130Hz (Setra Systems, Inc., Boxborough, MA, USA). The dynamic response 
of the servo-null system relative to the actual pressure is shown in figure 2  
Figure 2. Dynamic frequency 
response of the servo-null system.  
Panel A demonstrates the amplitude 
transfer curve of the measured 
pressure signal over a frequency 
range of 0.5 to 20Hz relative to the 
actual pressure. Panel B 
demonstrates the phase delay curve 
of the signal. 
 
We conclude that at the HR frequency (2-3Hz) the signal amplitude is amplified (under 
damped) by about 1% only and the phase delay is about 5-6 degrees, or 7ms, or about ¼ of 
the frame time interval. For the 4th harmonic (10Hz)(at 4 times the HR frequency), where still 
2-3% of the signal energy is present in the energy spectrum, the signal amplitude is amplified 
by about 20% and the phase delay is 25-30 degrees, or 8ms, or about ¼ of the frame time 
interval. We therefore conclude that the pressure is measured with sufficient accuracy. 
Furthermore, to avoid aliasing of higher frequencies into the low frequency domain, pressure 
data were filtered with a 2nd order low-pass Butterworth filter (Krohn-Hite Corporation, 
Brockton, MA, USA) set at the sampling frequency.  
 
Intraventricular volume  
During the pressure measurements the ventricle was visualised using video imaging with a 
stereo microscope (model SV 6, Carl Zeiss, Oberkochen, Germany) and a video camera 
(model SSC-M370CE, Sony Corporation, Tokyo, Japan). The video images were acquired 
simultaneously with the analog pressure signal at 50Hz and stored on a PC. Epicardial surface 
area was calculated from magnified video images displaying the ventricle using a custom-
built analysis program (IMAQ Vision, National Instruments, Austin, TX, USA). Ventricular 
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volume (V) was derived from epicardial area (A) using a simplified ellipsoid geometric 
model: V=0.65A3/2 as described by Keller et al 9.  
For each clipped and control embryo 2-4 consecutive (baseline) cardiac cycles were analyzed.  
Furthermore, to evaluate ventricular response to reduced venous return, a fourth order 
vitelline vein was incised to produce venous hemorrhage, which results in acute preload 
reduction. The cardiac cycles following hemorrhage were also recorded and subsequently 
analyzed to derive ventricular pressure-volume relations. By the latter procedure information 
can be obtained about ventricular contractility (through the end-systolic pressure volume 
relation) and diastolic stiffness (through the end-diastolic pressure volume relation). 
Finally, maximum contraction of the heart with 2M NaCl was induced for determination of 
ventricular wall volume by video imaging. The solution (1-3µl) was applied directly on the 
ventricle. Cavity volume was calculated as total volume minus wall volume. We validated this 
method by a separate study in a set of four embryos at stage 21 in which wall volume 
obtained by video imaging was compared with wall volume obtained by the counting method 
of Cavalieri, detailed by Gundersen and Jensen 18. The wall volume of the ventricles was 
determined after 2M NaCl application by video imaging, directly followed by fixation with 
4% paraformaldehyde in 0.1M phosphate buffer. The hearts were embedded in paraffin, 
serially sectioned at 5-µm thickness, and stained with hematoxylin-eosin for stereologic 
examination. The number of points on a grid hitting 15 sections of the ventricle was counted. 
The first section was taken randomly and the other sections were taken systematically. From 
the counted numbers, the volumes could be calculated by Cavalieri’s formula:   
V = Σ P . M -2 . a . d, where V is the volume in mm3 , Σ P  is the total number of counted 
points on the 15 sections, M the magnification, a is the point area in mm2 , and d is the 
distance between the counted sections in mm. 
The mean ventricular wall volume obtained by video imaging was 0.171 ± 0.009µl and mean 
myocardial wall volume obtained by Cavalieri’s method was 0.157 ± 0.010µl, which means 
that ventricular wall volume is overestimated by 8.9%. Therefore, we conclude that the video 
imaging procedure correlates well with stereologically obtained volumes and we chose not to 
correct for this overestimation in the calculations. 
 
Calculations  
All data were interpolated using a natural spline function (LabVIEW 6.0, National 
Instruments, Austin, TX, USA). Data analysis and calculations were performed using custom-
made software (Circlab, Leiden University Medical Center, Leiden, the Netherlands). For 
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each variable the mean value of 2-4 consecutive cardiac cycles was calculated. Pressure and 
volume data were plotted as pressure-volume loops (Fig. 3). End-systole is represented by the 
upper-left corner of the pressure-volume loops and was defined as the moment in the cardiac 
cycle with the maximum instantaneous pressure to volume ratio or time-varying elastance E(t) 
= P(t)/[V(t)-Vd] 19. Vd represent volume at zero pressure and was determined using an 
iterative approach as described by Kono et al 20. 
The lower-right corner of the pressure-volume loop represents end-diastole as the onset of 
ventricular contraction and was defined as the point at which the first derivative of the 
pressure waveform rose sharply from baseline. End-systolic and end-diastolic ventricular 
pressures and volumes (ESP, EDP, mmHg; ESV, EDV, µl) were determined as the 
instantaneous values P(t) and, respectively, V(t) at these time-points. Heart rate (HR, bpm) 
was calculated from the beat-to-beat cycle length. Stroke volume (SV, µl) was calculated as 
the difference between EDV and ESV. Cardiac output (CO, µl/min) was calculated as HR 
multiplied by SV. Ejection fraction (EF, %) was determined by SV divided by EDV. Stroke 
work (SW, µl⋅mmHg) was calculated as the area of the pressure-volume loop. The maximum 
and minimum first derivatives of pressure were determined (dP/dtMAX, dP/dtMIN, mmHg/s). 
Peak filling rate (PFR, µl/s) and peak ejection rate (PER, µl/s) were identified as the 
maximum and minimum first derivatives of ventricular volume with respect to time 
(dV(t)/dt). The relaxation time constant Tau (τ, ms) was calculated as the time-constant of 
mono-exponential pressure decay during isovolumic relaxation. The isovolumic period was 
defined as the time-period between the moment of dP/dtMIN and the time-point at which 
dP(t)/dt reached 10% of dP/dtMIN 21. In addition we calculated pressure-half-time (PHT, ms) 
as the time-interval between the moment of dP/dtMIN and the moment that pressure has 
dropped to 50% of the instantaneous pressure at the moment of dP/dtMIN.  
In addition to these steady state indices we employed the baseline pressure-volume loops 
combined with loops obtained after venous hemorrhage to determine systolic and diastolic 
pressure-volume relationships as load-independent measures of systolic and diastolic 
ventricular function. Systolic function was characterized by end-systolic elastance (EES, 
mmHg/µl), which is the linear slope of the end-systolic pressure-volume relation (ESPVR) 
(Fig. 4). Also the position of the ESPVR defined as the volume-intercept at 2mmHg (ESV2, 
µl) was determined in order to quantify the volume-intercept at a physiological pressure, 
rather than at pressure equals zero 22. 
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Diastolic ventricular function was determined by calculating diastolic stiffness (EED 
mmHg/µl) as the slope of the end-diastolic pressure-volume relation (EDPVR): EDP = a + 
EED⋅EDV 23.  
 
Statistical analysis  
Data are presented as mean ± SEM. For comparison of the clipped embryos with control 
embryos unpaired t tests were performed using SPSS 10.1 software (SPSS Inc, Chicago, IL, 
USA). When Levene’s test showed inhomogeneity of variance or when the data were not 
normally distributed according to the Shapiro-Wilk test, a log (ln) transformation was 
performed before testing group differences 24. Values p<0.05 were considered statistically 
significant. 
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Results 
Steady state hemodynamic parameters were determined from baseline pressure and volume 
signals and corresponding pressure-volume loops as depicted in Figure 3. Results are 
summarized in Table 1. and do not reveal any significant difference between clipped and 
control embryos. 
Figure 4. shows representative pressure-volume loops from a clipped and a control embryo. 
The grey lines represent loops at baseline, whereas the black lines are loops obtained after 
hemorrhage induced by incision of a fourth order vitelline vein. End-systolic and end-diastolic 
pressure-volume points are marked and the resulting pressure-volume relations are indicated. 
Note that, compared to the control embryo, in the clipped embryo the ESPVR was less steep 
indicating reduced contractility, whereas the EDPVR was steeper indicating increased 
diastolic stiffness (reduced compliance). The summarized results are shown in Table 2. and 
show a significantly reduced contractility (p=0.037) in the clipped embryos indicated by a 
52% reduction in EES. Diastolic stiffness tended to be increased in the clipped embryos as 
indicated by the 64% increase in EED, however the difference did not reach statistical 
significance (p=0.103). Ventricular wall volume was obtained after application of 2M NaCl 
and was not significantly different between the clipped and control embryos (0.195±0.013µl 
vs. 0.181±0.017µl, NS). 
Figure 3. Representative stage 21 baseline pressure-volume loops (C) built up from simultaneously 
acquired pressure (A) and volume data (B). Solid circles depict end-diastolic points, and open circles 
depict end-systolic points (C). Also end-diastolic points are represented by dotted lines in panels A 
and B.  
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Table 1. Hemodynamic parameters derived from baseline pressure-volume loops at stage 21.  
 
Values are means ± SEM. None of the 
parameters were significantly different between 
clipped and control embryos. dP/dtMIN, PER, Tau 
and PHT were not normally distributed. 
Consequently t-tests were performed after log 
transformation (using absolute values for 
dP/dtMIN and PER) as described in the methods 
section. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. End-systolic ventricular elastance (EES), end-diastolic ventricular stiffness (EED) and 
ESV at P=2mmHg obtained from pressure-volume relations. 
 
Values are means ± SEM. * p < 0.05. 
EES, EED and ESV2 demonstrated 
inhomogeneity of variances. Therefore, 
a log (ln) transformation was 
performed prior to performing t-tests. 
 Clip (n=11) Control (n=10)
   
HR (bpm) 
 
131±2 140±5 
ESP (mmHg) 
 
2.20±0.07 2.14±0.13 
EDP (mmHg) 
 
0.84±0.05 0.71±0.06 
dP/dtMAX (mmHg/s) 
 
41.3±1.8 37.8±2.6 
dP/dtMIN (mmHg/s) 
 
-43.2±2.7 -40.0±3.3 
ESV (µl) 
 
0.20±0.02 0.20±0.02 
EDV (µl) 
 
0.41±0.02 0.41±0.02 
SV (µl) 
 
0.25±0.02 0.24±0.01 
CO (µl/min) 
 
32.2±2.3 32.6±1.3 
EF (%) 
 
59.3±3.0 57.7±2.5 
SW (µl•mmHg) 
 
0.44±0.03 0.42±0.03 
PFR (µl/s) 
 
3.17±0.36 3.55±0.40 
PER (µl/s) 
 
-4.33±0.39 -4.11±0.42 
 
Tau (ms) 
 
31.41±3.16 39.02±6.20 
PHT (ms) 
 
22.67±1.66 25.43±4.54 
 Clip (n=11) Control (n=10) 
   
EES (mmHg/µl) 
 
5.68±0.85* 11.76±2.70 
EED (mmHg/µl) 
 
2.74±0.56 1.67±0.21 
ESV2 (µl)  
 
0.16±0.02 0.18±0.01 
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Figure 4. Representative 
pressure-volume loops of a 
clipped and a control 
embryo at stage 21. Both 
baseline-loops (grey lines) 
and loops after venous 
hemorrhage (black lines) are 
depicted of a clipped (A) 
and control embryo (B). The 
end-systolic points (open 
circles) and end-diastolic points (solid circles) were determined and were used to assess the end-
systolic pressure-volume relation (ESPVR) and end-diastolic pressure-volume relation (EDPVR). 
From these relations the end-systolic elastance (EES) and the end-diastolic stiffness (EED) were 
obtained, which are defined by the slopes of both relations, respectively 
 
 
Discussion 
The venous clip model is an intervention model for the chick embryo, in which permanent 
obstruction of the right lateral vitelline vein temporarily reduces the mechanical load on the 
embryonic myocardium and induces a spectrum of outflow tract anomalies, e.g. double outlet 
right ventricle, dextroposition of the aorta, and ventricular septal defects. The same types of 
anomalies can be present in humans. There is an intricate relationship between hemodynamics 
and cardiac morphogenesis. Pressure-volume loop analysis enables determination of end-
systolic elastance and end-diastolic stiffness of the developing ventricle. These parameters 
represent intrinsic myocardial properties and are relatively independent of loading conditions. 
The use of pressure-volume loop analysis in early stages of development could contribute to a 
better understanding of the relationship between cardiac function and morphogenesis during 
normal and abnormal cardiac development.  
The cardiac cycle consists of four distinct phases: the isovolumic contraction phase, the 
ejection phase, the isovolumic relaxation phase and diastolic filling phase. Parameters that 
reflect the first two phases are dP/dtMAX (isovolumic contraction phase), and cardiac output, 
ejection fraction, stroke work, and end-systolic elastance (ejection phase). From these 
parameters only the end-systolic elastance was significantly changed in the clipped embryos. 
This may reflect the high sensitivity of this load-independent parameter of contractility 
compared to the other parameters that are also changed by alterations in pre- and afterload. 
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The reduced end-systolic elastance indicating reduced contractile state can be explained by 
observations of Hogers et al 25. They observed less developed ventricles after venous clipping 
and a delay in cardiac looping. They did not observe normal embryos between stage 19 and 
23 after clipping. All embryos displayed cardiovascular malformations. They found that 
stages 22-24 are critical for survival. A mortality rate between 10 and 22% is described. At 
later stages of development approximately 64% of the embryos displayed cardiac 
malformations 4. Normally, myocardial contraction force increases with development 5,26-29. 
After clipping ventricular contractility development may lag behind as a consequence of 
impaired cardiac development. Mechanical load regulates ventricular growth 30,31. Venous 
obstruction temporarily reduces mechanical load on the myocardium and thus probably slows 
down the ventricular growth and differentiation process 3. During normal development the 
ventricular wall volume will increase in size. Since a delay in ventricular development was 
observed by Hogers et al. 25, we would have expected wall volume to be smaller in the 
clipped embryos. However, after applying 2M NaCl to achieve maximum ventricular 
contraction, ventricular wall volume was similar between the groups. Potentially the reduced 
contractility in the clipped embryos limits their maximal contracture leading to an 
overestimation in wall volume. 
The third phase of the cardiac cycle, the active phase of relaxation represented by Tau, 
reflects the energy consuming process of relaxation. In the mature heart ventricular relaxation 
rate is an important determinant of the early diastolic pressure-volume relation 32. There were 
no significant differences in the active phase of relaxation between the two groups.   
The end-diastolic pressure-volume relationship reflects passive relaxation properties of the 
ventricle, which contribute to the passive relaxation phase during diastolic filling. The relation 
was quantified by its slope, the end-diastolic stiffness, which was 64% higher in the clipped 
group. Although this was not a significant difference, this finding suggests reduced 
compliance after clipping. Myocardial compliance increases with development 9,28,33. A 
higher end-diastolic stiffness after venous obstruction may result from impaired cardiac 
development after clipping. Changes in structure of the ventricular wall may affect the 
stiffness of the ventricle, especially the addition and organisation of myofibrils may limit cell 
distensibility 34. Normally, myofibrils become more organised with development, and assume 
a more orderly arrangement, presumably parallel to stress lines 5. After venous obstruction 
this could be impaired. Next to the organisation of myofibrils, titin is also important for 
passive stiffness 35. Titin contains passive spring-like properties that help restore stretched 
muscle to its resting length 36.  Diastolic pressure results from the tension that develops when 
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passive myocardium is stretched beyond its slack length. In dogs with tachycardia-induced 
dilated cardiomyopathy it has been demonstrated that titin isoform ratio changes cause an 
increase in myocardial stiffness 37. We speculate that titin isoform expression ratios may have 
been changed by clipping, causing increased passive stiffness.  
Changes in diastolic function may be a critical regulatory pathway during cardiac 
morphogenesis 34. Recently Schroder et al. found an increase in microtubule density and β-
tubulin protein after reduced mechanical load in the stage 27 embryonic heart after left atrial 
ligation at stage 21 31. They observed increased myocardial stiffness in response to reduced 
mechanical load. They hypothesized that because microtubules mediate the transport of 
materials necessary for the production of new cellular structures, they may also play a role in 
mediating the adaptive response of the developing myocardium to altered mechanical load. 
Since in the venous clip model mechanical load is reduced it could be possible, that changes 
in microtubule density and organisation caused the tendency of increased diastolic stiffness in 
the clipped embryos. A decrease in workload may affect the number of contractile units or 
their function within the myocyte. Recently we observed a reduction in the diastolic passive-
filling component of ventricular filling in favor of the active component in clipped embryos at 
stage 24 38. We speculate that a stiffer ventricular wall causes this decrease in passive filling, 
which is compensated by the active contraction of the atrium. It seems that at stage 21 the 
ventricle is just starting to become stiffer.  
 
Study limitations: 
There are several limitations to the present study. Like Tobita and Keller 29,39 we assumed that 
the embryonic ventricle is a thick-walled ellipsoidal shell with a fixed ratio of semiminor and 
semimajor axis diameter during systole. This could lead to error in the calculation of 
ventricular wall volume and cavity volume.  
As demonstrated by our study in which the calculation of ventricular wall volume and 
assessing cavity volume was compared to volumes obtained by Cavalieri ‘s method, there is a 
overestimation of ventricular wall volume by 8.9%. In theory this means that cavity volumes 
are underestimated by about 0.016-0.017µL. Since this represents, even for the smallest 
volumes (mean end-systolic volume was 0.20µL), only about 8.7% of cavity volume we 
chose not to correct for this factor. Furthermore since this would cause a rightward shift of the 
entire pressure-volume loops, it has no consequences for the slopes of the pressure-volume 
relations. 
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We considered trabecular spaces to be part of the wall. These spaces do not close completely 
after application of 2M NaCl, but for the calculation of ventricular volume this is not very 
important. These spaces are present during both diastole and systole. This results in a slight 
overestimation of total volumes throughout the cardiac cycle. Therefore, when wall volume is 
subtracted from the total volumes this overestimation is cancelled out. Any remaining 
trabecular space volume can be considered dead volume, as this blood does not contribute to 
cardiac output. 
Because we only obtained pressure and volume data before and after hemorrhage and not 
during this preload reduction we chose linear relationships to describe the ESPVR and 
EDPVR. This may have influenced our results, but since the pressure-volume relations were 
based on only two conditions (rather than on data acquired continuously during preload 
reduction) there was no justification for applying a non-linear fit. Possible non-linearities 
might have been detected when the ESPVR had been determined over a wider pressure range. 
However, systolic pressure was similar in both groups, thus comparison of EES between 
groups is unlikely to be importantly affected by a pressure-dependent non-linearity.  
There were distinct differences in variances of the EES and EED between the clipped and 
control embryos before log (ln) transformation. Several factors may be involved. The chick 
embryos are not genetically identical, this could cause biological variability. Also the clipping 
experiment could have been partially successful, which could affect the outcome. There could 
have been some influence of the extent of hemorrhage. In theory, loading conditions do not 
influence the end-systolic pressure-volume relation or the end-diastolic pressure-volume 
relation. However, in the small chick embryo this might be different. Also the position of the 
embryo and/or micropipette could have been changed during the incision of a fourth order 
vitelline vein. This could have caused some variation as well. Furthermore, temperature 
differences could have influenced the measurements as time to insert the micropipette into the 
ventricle varied between experiments. However, whereas these effects may increase within-
group variability, they would not be expected to systematically affect the differences between 
the groups.  
Because of the necessity to end the experiments with the use of 2M NaCl it was impossible to 
obtain good histological examinations of the measured embryonic hearts. Therefore, we 
compared our results with scanning electron microscope and histological findings of Hogers 
et al., who developed the venous clip model. Any existing discrepancies in morphological 
findings between our data and those of Hogers et al. could therefore not be detected.  
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In summary, development of ventricular function in the embryonic heart is affected by 
mechanical load. Pressure-volume loop analysis shows that one day after venous obstruction 
the clipped embryo has a reduced contractility compared to stage-matched control embryos. 
The morphological correlates of these findings require further study. Pressure-volume 
analysis may be applied in the chick embryo and is a sensitive technique to detect subtle 
alterations in ventricular function. 
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4.2 Impaired systolic and diastolic ventricular function after permanent extra-
embryonic venous obstruction, a pressure-volume loop assessment in the stage 
24-chick embryo 
In preparation 
 
Summary 
Fluid mechanical forces affect cardiac development. In the chick embryo, permanent 
obstruction of the right lateral vitelline vein reduces the mechanical load on the embryonic 
myocardium, which has been shown to induce a spectrum of outflow tract anomalies. Insight 
into the effects of this intervention on the mechanical function of the developing myocardium 
could contribute to a better understanding of the relationship between hemodynamics and 
cardiac morphogenesis. 
Cardiac pressure-volume relations enable a load-independent quantification of intrinsic 
ventricular systolic and diastolic properties. We determined ventricular function by pressure-
volume loop analysis of in-ovo chick embryos (n=15) at stage 24 (4.5 days of incubation) 
after venous obstruction at stage 17. Control embryos (n=15) were used for comparison. 
End-systolic volume was significantly higher in clipped embryos (0.36±0.02µl vs. 
0.29±0.02µl, p=0.002).  End-systolic pressure and end-diastolic pressure were also increased 
as compared to control animals (2.93±0.07mmHg vs. 2.70±0.08mmHg, p=0.036 and 
1.15±0.06mmHg vs. 0.82±0.05mmHg, p<0.001). No significant differences were 
demonstrated for other baseline hemodynamic parameters. 
Analysis of pressure-volume relations showed a significantly lower end-systolic elastance in 
the clipped embryos (EES, slope of end-systolic pressure-volume relation: 2.91±0.24 vs. 
7.53±0.66mmHg/µl, p<0.005) indicating reduced contractility. Diastolic stiffness was 
significantly increased in the clipped embryos (EED, slope of end-diastolic pressure-volume 
relation: 1.54±0.21vs 0.60±0.08, p<0.005), indicating reduced compliance. 
We conclude that venous obstruction interferes with normal myocardial development 
resulting in impaired intrinsic systolic and diastolic ventricular function. These changes in 
ventricular function may precede morphological derangements in later developmental stages. 
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Introduction 
Human cardiac development takes place within the first 10 weeks of pregnancy. Despite 
technological advancements in ultrasonography we are still unable to adequately visualize the 
embryonic heart this early in gestation. Therefore, animal models are required to study in-vivo 
embryonic cardiovascular development. The chick embryo is an attractive model because it 
enables direct visualization of the heart and its cardiac development is comparable to that of 
mammalian embryos 40. 
Recent studies indicate that cardiac morphogenesis depends on the interaction between 
genetics and epigenetic influences like fluid mechanical forces 16. We previously developed 
an intervention model for the chick embryo (the venous clip model) in which intracardiac 
blood flow patterns and mechanical load on the embryonic myocardium are altered, leading to 
a spectrum of outflow tract anomalies 3,4 As blood flow is acutely decreased for up to 5 hrs 
after clipping at stage 17 3,8, this model supports the hypothesis that alterations in shear stress 
play an important role in the development of cardiac anomalies presumably through shear 
stress responsive gene expression.  
Insight into the effects of this intervention on the mechanical function of the developing 
myocardium could contribute to a better understanding of the relationship between 
hemodynamics and cardiac morphogenesis. Previous studies described that venous clipping 
can influence systolic and diastolic ventricular function. Using pressure-volume loop analysis 
we demonstrated the presence of a less contractile ventricle one day after clipping (HH21)41. 
Furthermore, 2 days after clipping (HH24), we showed that diastolic ventricular filling is 
disturbed using simultaneous Doppler measurements of the dorsal aorta and atrioventricular 
canal 38.  
In the present study we explored the effects of clipping on intrinsic systolic and diastolic 
ventricular function at stage 24, 2 days after venous obstruction. Pressure-volume loop 
analysis of the embryonic chick heart was performed using a custom-made workstation to 
simultaneously measure intraventricular pressure and capture video images of the beating 
ventricle for ventricular volume assessment.  
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Materials and Methods 
Animals and venous clip procedure 
Fertilized white Leghorn chick eggs (Gallus gallus (L.)) were obtained from Charles River 
Laboratories (Extertal, Germany) and were incubated at 37-38°C, with the blunt end up and at 
a relative humidity of 70-80%. The embryos were exposed by creating a window in the shell 
and removing the overlying membranes. Thirty embryos of stage 17 that showed no bleeding 
or deformities were selected. The material was subdivided into venous clipped embryos 
(n=15), in which the right vitelline vein was obstructed with an aluminum microclip, and 
control embryos (n=15). A more detailed description of this procedure has been published 
previously 3. During the experiments the egg was placed on a thermo element of 37°C. After 
the intervention the window in the shell was resealed with tape. Experiments were approved 
by the Animal Experimentation Review Board of the Erasmus MC and were performed in 
accordance with Dutch Law for animal experimentation.  
 
Figure 1. Frontal view of embryonic chick 
heart at stage 24 (4.5 days of incubation). 
A, atrium; V, ventricle; PF, primary fold; 
OFT, outflow tract. The future right and left 
ventricle are functioning as one ventricle at 
this developmental stage. Therefore, we 
used the entire ventricular area to determine 
volume. The ventricle was punctured with 
the glass micropipette in the area indicated 
by the arrow. 
 
 
Intraventricular pressure  
Embryos were reincubated until stage 24 (4.5 days of incubation). After removing the tape, 
the embryo was gently turned towards the left side to obtain a clear frontal view of the 
ventricle (Fig.1). The thoracic wall was opened using a pair of fine forceps. Blood pressure 
was measured in the ventricle using a servo-null system (model 900A, World Precision 
Instruments, Inc., Sarasota, Florida, USA) and a fluid filled (2mol/l NaCl) 5-10µm glass 
micropipette attached to a microelectrode. Intraventricular pressure was calculated as the 
difference between the measured pressure and the pressure recorded when the tip of the 
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pipette was placed in the extra-embryonic fluid adjacent to the ventricular puncture site. 
Pressure data were sampled at 50Hz and stored on a PC. The working principle of this 
pressure transducer is described in detail by Heineman 17. The dynamic response of the 
system was tested over the frequency range of 0.5-20Hz (as this frequency range is relevant to 
chicken embryonic heart rate) as published previously and was found to be of sufficient 
accuracy 41. Furthermore, to avoid aliasing of higher frequencies into the low frequency 
domain, pressure data were filtered with a 2nd order low-pass Butterworth filter (Krohn-Hite 
Corporation, Brockton, MA, USA) set at the sampling frequency.  
 
Ventricular cavity volume 
During the pressure measurements the ventricle was visualised using video imaging with a 
stereo microscope (model SV 6, Carl Zeiss, Oberkochen, Germany) and a video camera 
(model SSC-M370CE, Sony Corporation, Tokyo, Japan). The video images were captured 
simultaneously with the analog pressure signal at 50Hz and stored on a PC. Epicardial surface 
area was calculated from magnified video images displaying the ventricle using a custom-
built analysis program (IMAQ Vision, National Instruments, Austin, TX, USA). Total volume 
(V) was derived from epicardial area (A) using a simplified ellipsoid geometric model: 
V=0.65A3/2 as described by Keller et al 9. Ventricular wall volume was determined using the 
same approach at the end of each study after induction of maximum ventricular contraction 
with application of  (1-3µl) 2mol/l NaCl directly on the ventricle. Ventricular cavity volume 
was calculated as total volume minus wall volume. 
 
Experimental protocol 
For each embryo 4-5 consecutive baseline cardiac cycles were recorded. Subsequently, a 
fourth order vitelline vein was incised to produce venous hemorrhage, which results in acute 
preload reduction. The cardiac cycles following hemorrhage were also recorded and 
subsequently analyzed to derive systolic and diastolic ventricular pressure-volume relations.  
 
Calculations  
Time-dependent pressure and volume signals were interpolated using a natural spline function 
(LabVIEW 6.0, National Instruments, Austin, TX, USA) and subsequently analyzed using 
custom-made software (Circlab, Leiden University Medical Center, Leiden, the Netherlands). 
Pressure and volume data were plotted as pressure-volume loops. End-systole is represented 
by the upper-left corner of the pressure-volume loops and was defined as the moment in the 
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cardiac cycle with the maximum instantaneous pressure to volume ratio or time-varying 
elastance E(t) = P(t)/[V(t)-Vd] 19. Vd represents volume at zero pressure and was determined 
using an iterative approach as described by Kono et al 20. The lower-right corner of the 
pressure-volume loop represents end-diastole as the onset of ventricular contraction and was 
defined as the point at which the first derivative of the pressure waveform rose sharply from 
baseline. End-systolic and end-diastolic ventricular pressures and volumes (ESP, EDP; ESV, 
EDV) were determined as the instantaneous values P(t) and, respectively, V(t) at these time-
points. Heart rate (HR) was calculated from the beat-to-beat cycle length. Stroke volume (SV) 
was calculated as the difference between EDV and ESV. Cardiac output (CO) was calculated 
as HR multiplied by SV. Ejection fraction (EF) was determined by SV divided by EDV. 
Stroke work (SW) was calculated as the area of the pressure-volume loop. From the volume 
signal peak filling rate (PFR) and peak ejection rate (PER) were identified as the maximum 
and minimum first derivatives of ventricular volume with respect to time (dV/dt). From the 
pressure signal the maximum and minimum first derivatives of pressure were determined 
(dP/dtMAX, dP/dtMIN). The isovolumic relaxation period was defined as the time-period 
between the moment of dP/dtMIN and the time-point at which dP/dt reached 10% of dP/dtMIN 
21. The relaxation time constant Tau (τ) was calculated as the time-constant of mono-
exponential pressure decay during isovolumic relaxation using P=A+B.exp(-t/tau), in which A 
and B are constants determined by the data 42. Pressure-half-time (PHT) was calculated as the 
time-interval between the moment of dP/dtMIN and the moment that pressure has dropped to 
50% of the instantaneous pressure at the moment of dP/dtMIN. For each parameter the mean 
value of 4-5 consecutive cardiac cycles was calculated.  
In addition to these steady state indices we employed the baseline pressure-volume loops 
combined with loops obtained after venous hemorrhage to determine systolic and diastolic 
pressure-volume relationships as load-independent measures of systolic and diastolic 
ventricular function. Systolic function was characterized by end-systolic elastance (EES), 
which is the linear slope of the end-systolic pressure-volume relation (ESPVR) (Fig. 2). The 
position of the ESPVR was defined as the volume-intercept at 2.8mmHg (ESV2.8). Diastolic 
ventricular function was determined by calculating diastolic stiffness (EED) as the slope of the 
end-diastolic pressure-volume relation (EDPVR): EDP=c+EED⋅EDV, in which c is a constant 
23.  
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Statistical analysis  
Data are presented as mean ± SEM. For comparison of the clipped embryos with control 
embryos unpaired t tests were performed using SPSS 10.1 software (SPSS Inc, Chicago, IL, 
USA). When data were not normally distributed according to the Shapiro-Wilk test, a log (ln) 
transformation was performed before testing group differences 24. Values p<0.05 were 
considered statistically significant. 
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Results 
Steady state hemodynamic parameters were determined from baseline pressure and volume 
signals and corresponding pressure-volume loops. Results are summarized in Table 1. All 
parameters were normally distributed except Tau and PHT. These parameters were 
transformed prior to statistical testing. ESV was significantly higher in clipped embryos 
(0.36±0.02µl vs. 0.29±0.02µl, p=0.002). Also ESP and EDP were increased as compared to 
control animals (2.93±0.07mmHg vs. 2.70±0.08mmHg, p=0.036 and 1.15±0.06mmHg vs. 
0.82±0.05mmHg, p<0.001). All other baseline parameters demonstrated no significant 
differences. 
Figure 2. shows representative pressure-volume loops from a clipped and a control embryo. 
The black loops represent baseline, whereas the grey loops were obtained after hemorrhage 
induced by incision of a fourth order vitelline vein. End-systolic and end-diastolic pressure-
volume points are marked and the resulting end-systolic and end-diastolic pressure-volume 
relations are indicated. Note that, compared to the control embryo, in the clipped embryo the 
ESPVR was less steep indicating reduced contractility, whereas the EDPVR was steeper 
indicating increased diastolic stiffness (reduced compliance).  
Figure 2. Representative pressure-volume loops of a clipped and a control embryo at stage 24. Both baseline-
loops (black) and loops after venous hemorrhage (grey) are depicted of a clipped (A) and control embryo (B). 
The end-systolic points (open circles) and end-diastolic points (solid circles) were determined and were used to 
assess the end-systolic pressure-volume relation (ESPVR) and end-diastolic pressure-volume relation (EDPVR). 
From these relations the end-systolic elastance (EES) and the end-diastolic stiffness (EED) were obtained, which 
are defined by the slopes of both relations, respectively. 
 
The summarized results are presented in Table 2. and show a significantly reduced 
contractility (p<0.001) in the clipped embryos indicated by a 61% reduction in EES. Diastolic 
stiffness was increased in the clipped embryos as indicated by 157% increase in EED,  
(p<0.001). 
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Ventricular wall volume was obtained after application of 2mol/l NaCl and was not 
significantly different between the clipped and control embryos (0.809±0.037µl vs. 
0.783±0.046µl, NS). 
 
Table 1. Hemodynamic parameters derived from baseline pressure-volume loops at stage 24.  
 
 
Values are means ± SEM.* p<0.05. Tau and 
PHT were not normally distributed. 
Consequently t-tests were performed after a log 
(ln) transformation as described in the methods 
section. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. End-systolic ventricular elastance (EES), end-diastolic ventricular stiffness (EED) and 
ESV at P=2.8mmHg obtained from pressure-volume relations. 
 
 
Values are means ± SEM. * p < 0.005. 
EED was not normally distributed. 
Therefore, a log (ln) transformation was 
performed prior to performing t-tests. 
 
 
 
 Clip (n=15) Control (n=15)
   
HR (bpm) 
 
160±4 164±3 
ESP (mmHg) 
 
2.93±0.07* 2.70±0.08 
EDP (mmHg) 
 
1.15±0.06* 0.82±0.05 
dP/dtMAX (mmHg/s) 
 
64.8±3.1 69.3±3.5 
dP/dtMIN (mmHg/s) 
 
-52.0±2.7 -52.9±2.1 
ESV (µl) 
 
0.36±0.02* 0.29±0.02 
EDV (µl) 
 
0.97±0.03 0.91±0.04 
SV (µl) 
 
0.72±0.03 0.69±0.04 
CO (µl/min) 
 
115±4 112±7 
EF (%) 
 
74.3±1.8 74.7±1.6 
SW (µl•mmHg) 
 
1.66±0.07 1.62±0.11 
PFR (µl/s) 
 
14.9±0.8 13.6±0.9 
PER (µl/s) 
 
-12.0±0.5 -11.4±0.8 
Tau (ms) 
 
27.4±1.9 27.4±1.8 
PHT (ms) 
 
18.2±1.0 17.8±0.8 
 Clip (n=15) Control (n=15) 
   
EES (mmHg/µl) 
 
2.91±0.24* 7.53±0.66 
EED (mmHg/µl) 
 
1.54±0.21* 0.60±0.08 
ESV2.8 (µl)  
 
0.31±0.02 0.30±0.01 
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Discussion 
Pressure-volume analysis has been widely used in both human and animal studies 10-12. Only a 
few studies have been conducted during embryonic or fetal development; in (near term) fetal 
lambs and chick embryos 9,13-15. We used this method to study the impact of early venous 
obstruction (HH17) on embryonic cardiovascular function in later development. The venous 
clip model is an intervention model for the chick embryo, in which permanent obstruction of 
the right lateral vitelline vein temporarily reduces the mechanical load on the embryonic 
myocardium and induces a spectrum of outflow tract anomalies, e.g. double outlet right 
ventricle, dextroposition of the aorta, and ventricular septal defects 4. The same types of 
anomalies can be found in humans.  
The findings of the present study extend the results that we obtained in a younger 
developmental stage, at HH21 41. The end-systolic elastance was already significantly lower 
(52% reduction) at stage 21 and this is even more pronounced at stage 24 (61% reduction). 
This indicates that the disturbed ventricular function is not repaired, but there seems to be an 
ongoing process that results in a less contractile ventricle. At stage 21 the diastolic stiffness 
tended to be higher, however this was not significant. At stage 24, we demonstrated 
aggravation of the process causing a stiffer ventricular wall, as well as a significantly 
increased diastolic stiffness, leading to a less compliant ventricle. As the embryonic ventricle 
is relatively non-compliant and compliance increases during development 9,28,33, our data 
suggest that this process lags behind after venous clipping.  
Both the decreased end-systolic elastance and the increased end-diastolic stiffness are in line 
with observations made by Hogers et al 25. They observed less developed ventricles after 
venous clipping and a delay in cardiac looping. Between stage 19 and 23 all embryos 
displayed cardiovascular malformations. Furthermore, they found that stages 22-24 are 
critical for survival, with a mortality rate up to 22%. Mechanical load regulates ventricular 
growth 30,31. Venous obstruction temporarily reduces mechanical load on the myocardium and 
thus probably slows down the ventricular growth and differentiation process, leading to 
decreased end-systolic elastance and increased end-diastolic stiffness. Recently, we also 
observed changes in ventricular diastolic filling in stage 24 using simultaneous Doppler 
measurements of the dorsal aorta and atrioventricular canal. We found a reduced diastolic 
passive-filling component of ventricular filling, which was compensated by an increased 
active-filling component in clipped embryos at stage 24 38. The findings of the current study 
support our hypothesis that a stiffer ventricular wall causes this decrease in passive filling, 
which is compensated by increased atrial contraction.  
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The changes in intrinsic characteristics of the ventricle also caused elevation of the ESV, ESP, 
and EDP. Probably these elevations result from adaptation of the embryonic ventricle in order 
to maintain cardiac output at an adequate level to assure steady blood supply to all organs. To 
meet the demands of the growing embryo cardiac output increases during normal 
development 6,7. The increase in dorsal aortic blood flow parallels embryonic growth, and this 
suggests that cardiac output and metabolic demands are coupled through feedback 
mechanisms 6. 
Alterations in hemodynamics can precede the onset of structural defects 43. The venous clip 
procedure causes changes in intracardiac blood flow patterns and decreased dorsal aortic 
blood volume flow, eventually leading to a spectrum of outflow tract anomalies 4. Alterations 
in blood volume flow influence the shear stress on the vessel wall 44. During normal cardiac 
development, cardiac performance increases 1,5 and results in gradually increasing shear stress 
that either induces or represses the expression of shear stress responsive genes in the 
endothelium and/or endocardium 45,46 . In vitro studies have demonstrated that especially 
changes in shear stress cause alterations in gene expression 47. After venous obstruction blood 
volume flow is acutely decreased 3. Therefore, it is possible that alterations in shear stress are 
involved in the development of cardiac anomalies after venous clipping. Recently our group 
demonstrated developmental stage-related cardiovascular expression of the transcription 
factor KLF-2 (Krüppel-like factor-2), ET-1 (endothelin-1) and NOS-3 (nitric oxide synthase-
3), which are shear stress responsive genes 48. Especially the ET-1 pathway seems to be 
important in cardiovascular development. ET-1 knockout mice demonstrate a spectrum of 
cardiovascular malformations, which strongly resemble those seen in our venous clip model 
49. This finding suggests that the endothelin cascade is important in heart development and 
might be involved in the development of the malformations induced by venous clipping.  
The question as to how the ET-1 pathway could be responsible for the impaired ventricular 
function at stage 21 and 24 remains to be answered. Our group is currently working on ET-1 
expression patterns in the embryonic heart after venous obstruction. ET-1 expression seems to 
be decreased in certain areas of the heart after venous clipping (unpublished data). We assume 
that the changes in intra-cardiac blood flow patterns leading to shear stress changes as 
described by Hogers et al. are responsible for this observation 4. We speculate that this 
impairment of the ET-1 pathway causes the functional changes, observed in this study.  
There are several limitations to the present study. Like Tobita and Keller 29,39 we assumed that 
the embryonic ventricle is a thick-walled ellipsoidal shell with a fixed ratio of semi minor and 
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semi major axis diameter during systole. This could lead to error in the calculation of 
ventricular wall volume and cavity volume.  
We considered trabecular spaces to be part of the wall. These spaces do not close completely 
after application of 2mol/l NaCl, but for the calculation of ventricular volume this is not very 
important. These spaces are present during both diastole and systole. This results in a slight 
overestimation of total volumes throughout the cardiac cycle. Therefore, when wall volume is 
subtracted from the total volumes this overestimation is cancelled out. Any remaining 
trabecular space volume can be considered dead volume, as this blood does not contribute to 
cardiac output. 
Because we only obtained pressure and volume data before and after hemorrhage and not 
during this preload reduction we chose linear relationships to describe the ESPVR and 
EDPVR. This may have influenced our results, but since the pressure-volume relations were 
based on only two conditions (rather than on data acquired continuously during preload 
reduction) there was no justification for applying a non-linear fit. Possible non-linearities 
might have been detected when both relations would have been determined over a wider 
pressure range.  
Because of the necessity to end the experiments with the use of 2mol/l NaCl it was impossible 
to obtain good histological examinations of the measured embryonic hearts. Therefore, we 
compared our results with scanning electron microscope and histological findings of Hogers 
et al., who developed the venous clip model. Although not expected, possible discrepancies in 
morphological findings between our data and those of Hogers et al. could therefore not be 
detected.  
Considering these limitations, however we have no reason to assume that potential errors are 
different for the control and experimental groups. 
 
In summary, development of ventricular function in the embryonic heart is affected by 
mechanical load. Pressure-volume loop analysis shows that two days after venous obstruction 
clipped embryos have reduced contractility and increased diastolic stiffness compared to 
stage-matched control embryos. Therefore, we conclude that venous obstruction interferes 
with normal myocardial development resulting in adverse effects on intrinsic systolic and 
diastolic ventricular function. These changes in ventricular function may precede 
morphological derangements in later developmental stages. 
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Introductory remarks 
Ventricular diastolic filling is an important feature of the ventricle as it determines preload 
and thus cardiac output. Diastolic filling can be partitioned into a passive filling component 
and an active filling component. During the passive phase blood flows from the atrium to the 
ventricle due to the pressure-gradient. Hereafter, active filling is established by atrial 
contraction. During development the ratio of passive to active filling volume decreases 
because the active filling increases geometrically. The atrioventricular flow pattern may be a 
mechanical-biologic link to ventricular chamber growth and a determination of ventricular 
chamber volume. The venous clip procedure temporarily reduces the mechanical load on the 
myocardium. Therefore, we investigated the influence of the venous clip intervention on 
ventricular diastolic filling characteristics at stage 24 using simultaneous Doppler 
measurements over the dorsal aorta and atrioventricular canal. Furthermore, the influence of 
endothelin-1 or endothelin receptor antagonist infusion on ventricular diastolic filling was 
established as well.  
 
5.1 Ventricular diastolic filling characteristics in stage 24 chick embryos after extra-
embryonic venous obstruction  
Journal of Experimental Biology 2004; 207:1487-1490 
 
Summary 
Alteration of extra-embryonic venous blood flow in stage 17 chick embryos results in well-
defined cardiovascular malformations. We hypothesise that the decreased dorsal aortic blood 
volume flow observed after venous obstruction results in altered ventricular diastolic function 
in stage 24 chick embryos. A microclip was placed at the right lateral vitelline vein in a stage 
17 (52-64 h of incubation) chick embryo. At stage 24 (4.5 days of incubation), we measured 
simultaneously dorsal aortic and atrioventricular blood flow velocities with a 20-MHz pulsed-
Doppler velocity meter. The fraction of passive and active filling was integrated and 
multiplied by dorsal aortic blood flow to obtain the relative passive and active ventricular 
filling volumes. Data were summarized as mean ± SEM and analyzed by t-test. At similar 
cycle lengths ranging from 557 to 635 ms (p>0.60), dorsal aortic blood flow and stroke 
volume measured in the dorsal aorta were similar in stage 24 clipped and normal embryos. 
Passive filling volume (0.07±0.01 mm3) was decreased and active filling volume (0.40±0.02 
mm3) was increased in the clipped embryo when compared to the normal embryo (0.15±0.01 
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mm3, 0.30±0.01 mm3, respectively) (p<0.003). In the clipped embryos, the passive/active 
ratio was decreased compared to normal embryos (p<0.001). Ventricular filling components 
changed after partially obstructing the extra-embryonic venous circulation. These results 
suggest that material properties of the embryonic ventricle are modified after temporarily 
reduced hemodynamic load.      
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Introduction 
The formation of the four-chambered heart is a complex and dynamic interaction between the 
basic gene program that regulates growth and differentiation and the mechanical forces 
generated by the functioning heart. To study the influence of hemodynamics on heart 
morphogenesis, we used a chick embryo intervention model in which extra-embryonic blood 
flow can be manipulated. Intracardiac blood flow patterns were altered by a redirection of 
venous inflow through permanent obstruction of the right vitelline vein with a microclip. We 
previously showed that this intervention produced a specific set of cardiac malformations, 
namely ventricular septal defects, valve anomalies and pharyngeal arch artery malformations 
1,2. The similarity of these structural cardiac anomalies in the chick embryo to those observed 
in patients with congenital heart disease argues for the importance of intracardiac 
hemodynamics as a key epigenetic factor in embryonic cardiogenesis 3. 
We recently demonstrated that venous clipping has major acute effects on hemodynamics in 
the stage 17 chick embryo 4. For the total study period of five hours, dorsal aortic blood flow 
remains lower compared to baseline values, whereas heart rate shows a recovery to baseline 
within two hours after clipping 4. This dramatic reduction in total circulating blood volume 
after clipping could influence the functional characteristics of the embryonic heart. Since the 
early developing cardiovascular system is not yet innervated 5, cardiovascular function is 
sensitive to mechanisms or interventions that alter hemodynamic load like in the venous clip 
model. In contrast to the mature cardiovascular system, the embryonic heart lacks the ability 
to acutely alter heart rate to compensate for reduced ventricular preload 6. We therefore, 
hypothesize that the decreased blood volume flow observed in the venous clip embryo would 
affect ventricular diastolic function.  
Embryonic diastolic function can be investigated using pulsed-Doppler measurements of 
blood velocity and flow. The combination of simultaneous atrioventricular and dorsal aortic 
blood flow profiles accurately defines passive and active ventricular filling volumes 7. We 
studied embryonic cardiovascular performance in the stage 24-chick embryo during normal 
growth and development and after venous clip intervention. 
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Material and Methods 
Fertilized White Leghorn chicken (Gallus domesticus L.) eggs (Charles River Laboratories, 
Extertal, Germany) were incubated blunt-end up at 37-38ºC and staged according to 
Hamburger and Hamilton 8. Embryos that were dysmorphic, exhibited arrhythmias or overt 
bleeding were excluded. At stage HH 17 (52-64 h of incubation) the embryo was exposed by 
creating a window in the shell followed by removal of the overlying shell membranes. 
Adjacent to the right lateral vitelline vein, the vitelline membrane was removed and a small 
incision was made in the yolk sac membrane. An aluminum microclip was used to clip the 
right lateral vitelline vein 1,2. After venous ligation, the window was sealed with tape and the 
eggs returned to the incubator until stage HH 24 (4.5 days of incubation). 
Dorsal aortic blood flow velocity and atrioventricular (AV) blood flow velocity were recorded 
using a 20-MHz pulsed Doppler velocity meter (model 545C-4, Iowa Doppler Products, Iowa 
City, USA). Dorsal aortic blood velocity was measured with a 750-µm piezoelectric crystal 
positioned at a 45º angle towards the dorsal aorta at the level of the developing wing bud. 
Internal aortic diameter was calculated from a magnified video image displaying the dorsal 
aorta using a custom-built analysis program (IMAQ Vision, National Instruments, Austin, 
TX, USA) 9. Atrioventricular blood flow velocity was measured with a second crystal 
positioned at the apex of the heart towards the AV orifice. The Doppler audio signals were 
digitized at 24 kHz and stored on hard disk. Using complex fast Fourier transform analysis, 
the maximum velocity waveform was reconstructed. A more detailed description of this 
method has been published previously 9. Passive filling (P) was defined in the AV flow 
velocity waveform from end-systole to the onset of the A-wave, and active filling (A) from 
the onset of the A-wave to the onset of systole (Fig. 1). Portions of passive and active filling 
overlapped each other at faster heart rates. The demarcation between the passive and active 
velocities was dependent on heart rate, but was most conspicuous as heart rate slowed. 
Therefore, heart rate was decreased to 100 bpm by cooling of the embryo. Although 
environmental temperature directly influences hemodynamics 10 a slowed heart rate of 
approximately 100 bpm was necessary to discriminate between the passive and active filling 
phase and to study both groups under similar conditions. Cycle length was defined as the time 
between consecutive beats obtained from the dorsal aortic velocity waveform. Dorsal aortic 
and both passive and active AV velocity profiles were integrated over time. Dorsal aortic 
blood flow, an estimate of cardiac output, was calculated as the product of the integrated 
velocity curve and the cross-sectional area of the dorsal aorta. Passive ventricular filling 
volume equaled dorsal aortic stroke volume multiplied by the fraction of passive filling area 
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and active ventricular filling volume equaled dorsal aortic stroke volume multiplied by the 
fraction of the active filling area 7.  
Fifteen clipped and fifteen normal embryos were measured at stage 24. For each embryo we 
analyzed five consecutive cycles. The data are presented as mean ± SEM and a statistical 
analysis was carried out using an unpaired t-test. When data was not normally distributed 
according to the Shapiro-Wilk test, a logarithmic transformation was performed prior to 
establishing difference between the two study groups. Statistical significance was reached at p 
< 0.05. Calculations were performed with SPSS 10.1 software (SPSS Inc, Chicago, IL). 
Fifteen clipped and fifteen normal embryos were measured at stage 24. For each embryo we 
analyzed five consecutive cycles. The data are presented as mean ± SEM and a statistical 
analysis was carried out using a paired t-test. Statistical significance was reached at p < 0.05. 
Calculations were performed with SPSS 10.1 software (SPSS Inc, Chicago, IL). 
 
Results 
The cycle length and heart rate were similar between the two study groups (p>0.60). The 
mean cycle length was 593 ± 7 ms in the clipped embryo and 597 ± 5 ms in the normal 
embryo corresponding to a mean heart rate of 101 ± 1 bpm vs. 100 ± 1 bpm in the clipped and 
normal embryo, respectively.  As a result of this slowed heart rate the passive and active 
filling phase of the AV velocity waveform during diastole were well defined (Fig. 1). The AV 
velocity waveform during ventricular systole coincided with the dorsal aortic flow velocity 
(Fig. 1). 
Dorsal aortic blood flow and stroke volume were similar in the clipped and normal embryos at 
stage 24 (Fig. 2 and 3). In the clipped embryos, mean passive ventricular filling volume 
decreased by 53%, while mean active ventricular filling volume increased 33%, when 
compared with normal controls (Fig. 3). The passive filling volume accounted for 15% of the 
stroke volume in the clipped embryos and 33% in the normal embryos. The ratio of passive to 
active ventricular filling volume was significantly decreased in the clipped embryos compared 
to normal embryos (0.19 ± 0.02 vs. 0.50 ± 0.04) (p<0.001). 
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Figure 1. 
An example of simultaneously recorded tracings of atrioventricular velocity (solid line) and dorsal 
aortic blood flow (dashed line) in a normal (upper panel) and clipped (lower panel) stage 24 chick 
embryo. Diastole is partitioned into two components: the passive phase indicated by P and the active 
phase indicated by A. 
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Figure 2.  
Dorsal aortic (DAo) blood flow and passive (P) and active (A) components of atrioventricular blood 
flow measured in normal (open bars, n=15) and clipped (solid bars, n=15) chick embryos at stage 24. 
Data presented as mean ± SEM. *p<0.003 vs. control. 
Figure 3. 
Dorsal aortic (DAo) stroke volume and passive (P) and active (A) ventricular filling volumes 
measured in normal (open bars, n=15) and clipped (solid bars, n=15) chick embryos at stage 24. Data 
presented as mean ± SEM. *p<0.003 vs. control. 
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Discussion 
The present study extends our ongoing investigation of embryonic cardiovascular function 
after venous clipping experiments at stage 17. We used simultaneous measurements of 
atrioventricular blood flow velocity and dorsal aortic blood flow to study ventricular diastolic 
filling characteristics after vitelline vein ligation. Our data of atrioventricular inflow patterns 
after venous clipping showed a reduced contribution of passive filling in favor of atrial 
contraction to ventricular filling at stage 24, whereas stroke volume measured in the dorsal 
aorta was similar between clipped and control embryos at this stage. 
Rerouting of venous inflow by permanent obstruction of the right vitelline vein in the early 
chick embryo results in cardiovascular malformations: ventricular septal defects, valve 
anomalies and pharyngeal arch artery malformations 2. Results of our hemodynamic study 
revealed that during the first five hours after clipping dorsal aortic blood flow is markedly 
decreased and is unable to return to baseline values 4. However, dorsal aortic blood flow 
measurements obtained 24 hours (stage 21) after clipping demonstrated similar results in 
clipped and control embryos (unpublished data). We suggest that the reduction in blood flow 
for at least five hours may begin a cascade of events that result in the cardiovascular 
malformations observed later during development.  
Proper functional loading is essential for normal cardiac morphogenesis, as the structure and 
function of the developing heart are intimately linked. Subjecting the chick embryonic heart 
to mechanically altered loading conditions modifies the myocardial architecture 11. Decreased 
mechanical loading of the left ventricle by left atrial ligation results in reduced levels of 
proliferation in the left ventricular compact layer and trabeculae 12. During normal maturation 
of the heart, myofibrils increase in number and alignment and this will probably affect the 
myocardial properties of the ventricle 13. In the same left atrial ligation model, Tobita et al. 14 
demonstrated an increase in passive stiffness of embryonic myocardium in response to 
reduced mechanical load. Microtubules, important regulators of cellular organization and 
fibrillogenesis, seem to be associated with the response of the embryonic myocardium to 
altered load. An increase in microtubular density and an acceleration of myofiber maturation 
were observed in the embryonic heart after altered mechanical load and were related to the 
increased passive stiffness noted after left atrial ligation 15.  
Venous clipping also reduces mechanical load and is likely to modify the myocardial 
architecture and this may subsequently result in increased passive stiffness of the embryonic 
myocardium. This is supported by morphologic examination of venous clipped embryos 
demonstrating, that in addition to delayed cardiac looping and impaired cushion formation, 
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the compact layer of ventricular myocardium was thinner and ventricular trabeculation was 
reduced 16. These morphological changes in developing myocardium could also have impact 
on diastolic function and contribute to observed changes in ventricular filling patterns. 
In contrast, data of atrioventricular inflow patterns after left atrial ligation showed reduced 
contribution of atrial contraction to ventricular filling and decreased peak velocity from stage 
21 to stage 27 17. In the left atrial ligation model the decrease in volume load is chronic, 
whereas in the venous clip model the reduction in volume load is temporary. We, therefore, 
suggest that the embryonic ventricle responds to temporarily reduced loading conditions by a 
change in ventricular passive properties resulting in a reduction in passive filling that is 
compensated by an increase of atrial contraction to maintain constant cardiac output. 
Experimental disruptions of the venous return by vitelline vein obstruction or left atrial 
ligation cause cardiovascular malformations 2,18. These observations indicate that responses of 
cardiac tissue to altered biomechanical forces including blood flow and shear stress are 
critical determinants of cardiac development. Also a role for hemodynamics in modulation of 
shape and arrangements of endocardial cells in the embryonic chick has been reported 19. In 
addition, cultured vascular endothelial cells rearrange their cytoskeletal architecture and 
change their gene expression profiles in response to flow-induced forces 20-23. Thus, 
experimentally induced flow alterations that translate fluid shear stress to changes in gene 
expression are likely candidate regulating mechanisms for the response of the developing 
heart to reduced loading conditions. The hypothesis that fluid shear stress plays an important 
role in embryonic cardiogenesis was recently substantiated by a study performed in zebrafish 
embryos. This study describes the quantitative in vivo analysis of intracardiac blood flow and 
shear stress in zebrafish embryos. Their data strongly suggest that shear stress forces play 
some role in the regulation of embryonic cardiogenesis 3. 
In conclusion, early venous obstruction results in altered diastolic ventricular filling of the 
stage 24-chick embryo. Our study supports the paradigm that alteration in mechanical loading 
is a mechanism that can produce changes in cardiac function and structure. 
                          
 
                                                                  95
5.2 Altered ventricular diastolic filling characteristics in HH24 chicken embryos 
after venous infusion of endothelin-1 and endothelin receptor antagonists at HH18 
In preparation 
 
Summary 
Cardiovascular malformations in the venous clip model for chicken embryos are similar to 
malformations observed in knockout mice studies of components of the endothelin-
1/endothelin-converting-enzyme-1/endothelin receptor A (ET-1/ECE-1/ETA) cascade. ET-1 
expression is decreased in the heart 3 hrs after clipping. Also ventricular diastolic filling is 
disturbed 2 days after clipping. Therefore, we hypothesize that the endothelin cascade is 
involved in the development of functional cardiac impairment and cardiovascular 
malformations after venous clipping.  
Endothelin-1 and endothelin receptor antagonists were infused into the blood stream of HH18 
embryos and ventricular diastolic filling characteristics were studied at HH24, followed by 
cardiovascular morphologic investigation at HH35. The results were compared to sham-
operated embryos. Furthermore, the effect of ET-1 and receptor antagonists on expression of 
ET-1, ECE-1, ETA, and Lung Krüppel-like factor (KLF2) was investigated, and the 
cardiovascular localisation of ETA and ETB receptor mRNA from HH18 to HH24 was 
determined using in situ hybridisation (ISH).  
We found a reduced diastolic passive-filling component of ventricular filling in embryos 
infused with ET-1, ETA and the combined ETA-ETB antagonist, which was more than 
compensated by an increased active-filling component. The passive-filling component was 
not affected after infusion of the ETB antagonist. In 42% of the experimental embryos a 
thinner ventricular myocardium was found compared to 20% in sham embryos. No major 
cardiovascular malformations were observed. In vitro administration of ET-1 or endothelin 
receptor antagonists confirmed that ETA and ETB receptors act differently within cardiac 
function. ISH revealed that ETA mRNA is predominantly expressed in the myocardium, 
whereas ETB is mostly expressed in the endocardium. 
The results found in the present study suggest that the endothelin pathway is involved in the 
development of functional cardiac impairment observed in the venous clip model and plays an 
important role in development of cardiac function in general. We conclude that cardiovascular 
malformations after venous clipping arise from a combination of hemodynamic changes and 
subsequent altered gene expression patterns, including those of the endothelin pathway.   
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Introduction 
The formation of the four chambered heart results from the complex and dynamic interaction 
between the basic gene program that regulates growth and differentiation and the mechanical 
forces generated by the functioning heart. When mechanical forces such as shear stress are 
impaired, or when genes involved in growth and differentiation are not functioning correctly, 
malformations may arise.  
In the venous clip model the right lateral vitelline vein of a chicken embryo is permanently 
ligated. Due to this ligation blood flow patterns through the heart are changed, resulting in 
functional cardiac impairment and cardiovascular malformations 2,24,25. For up to 5 hours after 
venous clipping, dorsal aortic mean and peak blood flows are decreased, leading to a decrease 
in shear stress 4. Previously, we have shown that the genes endothelin-1 (ET-1), Lung 
Krüppel-like factor (KLF2/LKLF), and endothelial nitric oxide synthase (NOS-3/eNOS) are 
shear related in vivo in the chicken embryo 26. After a 3-hour ligation the dorsal aortic 
expression of these genes is altered: ET-1 is increased, and KLF2 and NOS-3 are both down-
regulated (Groenendijk, unpublished). This confirms that indeed decreased aortic blood flow 
is accompanied by diminished local shear stress after venous clip. 
ET-1 is part of the endothelin-1/endothelin-converting-enzyme-1/endothelin receptor A (ET-
1/ECE-1/ETA) signalling cascade, which is important in cardiac development 27. The 
cardiovascular malformations in the venous clip model 28 are similar to the malformations 
observed in knockout mice studies of components of the ET-1/ECE-1/ETA cascade 27,29,30. In 
addition, ET-1 expression after a 3-hour venous clip is decreased in the heart (Groenendijk, 
unpublished). This suggests that the endothelin cascade might be involved in the development 
of malformations induced by venous clipping. 
In a previous study we demonstrated that ventricular diastolic filling is disturbed two days 
after clipping (HH24) 24. Using simultaneous Doppler measurements of the dorsal aorta and 
atrioventricular canal, we found a reduced diastolic passive-filling component of ventricular 
filling, which was compensated by an increased active-filling component in clipped embryos.  
To unravel the cascade of events thought to occur after venous clipping, we infused ET-1 and 
endothelin receptor antagonists into a vitelline vein at HH18. We studied embryonic 
ventricular diastolic function, using pulsed-Doppler measurements of blood velocity and flow 
in HH24 chicken embryos, two days after the extra-embryonic venous infusion. Furthermore, 
we examined the cardiovascular morphology of the infused embryos at HH35. This was done 
in order to test the hypothesis that disturbed ET-1 expression after venous clipping is 
responsible for the observed functional cardiac impairment and cardiovascular malformations 
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in this model. Both the ventricular diastolic filling and morphology were compared to the 
results of sham-operated embryos. To examine the possible influence on gene expression ET-
1 or endothelin receptor antagonists were also administered to endocardial cell cultures, after 
which gene expression was determined. The localisation of the mRNA of ETA and ETB 
receptors was investigated as well as ET-1 exerts its function through these receptors. 
 
Material and Methods 
Animals and intravenous infusions 
Fertilised White Leghorn chicken (Gallus domesticus L.) eggs (Charles River Laboratories, 
Extertal, Germany) were incubated blunt-end up at 37-38ºC and staged according to 
Hamburger and Hamilton 8. Embryos that were dysmorphic, exhibited arrhythmias or overt 
bleeding were excluded. At HH18 the embryos were exposed by creating a window in the 
shell followed by removal of the overlying shell membranes. Adjacent to the right lateral 
vitelline vein, the vitelline membrane was removed and a glass micropipette was inserted into 
one of the third order branches of the right lateral vitelline vein. One µl of the following 
substances was slowly infused without any force, to keep changes in hemodynamics to a 
minimum: endothelin 1 (Bachem, Brunschwig Chemie, Germany) at a concentration of 10-
7mol/L in Phosphate Buffered Saline (PBS) (n=16), the ETA antagonist BQ-123 (Bachem) 
(n=17) and ETB antagonist BQ-788 (Sigma-Aldrich) (n=18), both at a concentration of 10-5 
mol/L in PBS, and a combined ETA/ETB antagonist PD145065 (Sigma-Aldrich) at a 
concentration of 10-4 mol/L in PBS (n=17). Indigo carmine blue (0.25 g/mL) was added for 
visualization of the solution during in vivo infusion. The embryos were compared with sham-
operated animals (n=13) in which only PBS with indigo carmine was infused.  
After this extra-embryonic venous infusion, the window was sealed with tape and the eggs 
were reincubated for measurement of the blood flow velocity at HH24 (embryonic day 4.5). 
The embryos were sacrificed at HH35 (embryonic day 9) for histological examination. Prior 
to fixation the embryos and the hearts were macroscopically evaluated for overt 
malformations. 
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Measurements 
Dorsal aortic blood flow velocity and atrioventricular (AV) blood flow velocity were recorded 
using a 20-MHz pulsed Doppler velocity meter (model 545C-4, Iowa Doppler Products, Iowa 
City, USA). Dorsal aortic blood velocity was measured with a 750-µm piezoelectric crystal 
positioned at a 45º angle towards the dorsal aorta at the level of the developing wing bud. 
Internal aortic diameter was calculated from a magnified video image displaying the dorsal 
aorta using a custom-built analysis program (IMAQ Vision, National Instruments, Austin, 
TX, USA) 9. Atrioventricular blood flow velocity was measured with a second crystal 
positioned at the apex of the heart towards the AV orifice. The Doppler audio signals were 
digitised at 24 kHz and stored on hard disk. Using complex fast Fourier transform analysis, 
the maximum velocity waveform was reconstructed. A more detailed description of this 
method has been published previously 9. Passive filling (P) was defined in the AV flow 
velocity waveform from the end of the isovolumic relaxation period to the onset of the A-
wave, and active filling (A) from the onset of the A-wave to the onset the isovolumic 
contraction period (Fig. 1). Portions of passive and active filling overlapped each other at 
faster heart rates. The demarcation between the passive and active velocities was dependent 
on heart rate, but was most conspicuous as heart rate slowed. Therefore, heart rate was 
decreased to approximately 110 bpm by cooling of the embryo. Although environmental 
temperature directly influences hemodynamics 10 a slowed heart rate of approximately 110 
bpm was necessary to discriminate between the passive and active filling phase and to study 
both groups under similar conditions. Cycle length was defined as the time between 
consecutive beats obtained from the dorsal aortic velocity waveform. Dorsal aortic and both 
passive and active AV velocity profiles were integrated over time. Dorsal aortic blood flow, 
an estimate of cardiac output, was calculated as the product of the integrated velocity curve 
and the cross-sectional area of the dorsal aorta. The passive component of ventricular blood 
flow was defined as mean aortic blood flow multiplied by the fraction of passive filling area, 
and the active component of ventricular blood flow was defined as mean aortic blood flow 
multiplied by the fraction of the active filling area. Passive ventricular filling volume equalled 
dorsal aortic stroke volume multiplied by the fraction of passive filling area. Active 
ventricular filling volume equalled dorsal aortic stroke volume multiplied by the fraction of 
the active filling area 7.  
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Statistical analysis 
Eighty-one chicken embryos were measured at HH24. We compared embryos that received an 
infusion with ET-1, ETA antagonist, ETB antagonist, or ETA/ETB antagonists with sham 
embryos. For each embryo we analysed five consecutive cycles per measurement. The data 
are presented as mean ± SEM and a statistical analysis was carried out using an unpaired t-
test. When data was not normally distributed according to the Shapiro-Wilk test, a logarithmic 
transformation was performed prior to establishing difference between the study groups and 
sham embryos. Statistical significance was reached at p < 0.05. Calculations were performed 
with SPSS 10.1 software (SPSS Inc, Chicago, IL). 
 
Morphological and histological examination 
After the Doppler measurements at HH24 the embryos were reincubated until HH35. From 
the embryos that survived until this stage, we randomly selected embryos (n=6 per substance) 
for morphological and histological examination. 
Embryos were fixed in 4% paraformaldehyde in 0.1M phosphate buffer for 24 hrs, followed 
by dehydration in graded ethanol and were embedded in paraffin. After this the embryos were 
serially sectioned transversely to the arterial pole at 5µm and mounted on glass slides. 
Routine immunohistochemical staining was performed using an overnight incubation with the 
primary antibody HHF35 (DAKO, Denmark) against muscle actin 31 diluted 1:500 in PBS 
with 0.05% Tween-20 (PBST) and 1% Bovine Serum Albumin (BSA). After rinsing in PBS 
the sections were incubated with horseradish peroxidase-conjugated rabbit anti-mouse 
antibody (1:250, DAKO, Denmark) for 75 minutes. Following thorough rinsing with PBS, the 
sections were treated with 0.04% diaminobenzidine tetrahydrochloride (DAB)/0.0060/00 H2O2 
in 0.05mol/L Tris-maleic acid (pH 7.6) for 10 minutes at room temperature. The sections were 
counter-stained with Mayer’s Haematoxylin, dehydrated, and mounted in Entellan. 
 
Radioactive In Situ Hybridisation 
In a separate set of control embryos we determined the localisation of mRNA for the 
endothelin-1 receptors ETA and ETB in the chicken heart at HH18 (n=3, stage of infusion), 
HH20 (n=2), HH22 (n=2) and HH24 (n=2, stage of measurements), essentially as described 
before (Groenendijk et al., 2004). 35S-labelled chicken specific riboprobes were produced 
from a 845 bp (nucleotides 2256-3101) ETA fragment, and a 440 bp (nucleotides 339-778) 
ETB fragment, that were cloned in pBSK (ETA) or pCRII (Invitrogen, ETB). After 
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linearisation sense and antisense cRNA was transcribed in transcription buffer, 0.01mol/L 
dithiothreitol, 0.25mmol/L G/A/CTP mix, 1.4U/µL RNase-inhibitor, and 1.5U/µL of the 
appropriate RNA polymerase (ETB: SP6; ETA: T3) in the presence of 2.31MB 35S-UTP. 
Concentration of the probes was normalised to 1x105 cpm/µL. All sense probes showed 
negative hybridisation results (not shown).  
 
In vitro experiments 
To quantify the effect of exogenous endothelin and the receptor antagonists on expression of 
ET-1, ECE-1, ETA and KLF2 we added the substances to primary cultures of quail 
endocardial cells, and quantified expression levels by QRT-PCR. Fertilised quail (Coturnix 
coturnix) eggs were incubated to stage HH40 (14 days) at 37°C and 60-70% relative 
humidity, and were isolated. The ventricles of the embryos were used for isolation 
procedures. After opening along their longitudinal axes, the ventricles were incubated with 
the endocardial side down for 10 minutes at 37°C in 0.1% (w/v in PBS) Collagenase-A 
(Roche). The cells were flushed with medium, and by filtration on a 30µm filter (Miltenyi 
Biotec) sheets of cells were isolated. After this, the cells were seeded in fibronectin-coated 
(20µg/mL, Sigma) dishes in QEC medium consisting of M199/HEPES (Gibco) supplemented 
with 10% (v/v) Fetal Calf Serum (Gibco), 2% (v/v) Chicken Serum (Gibco), 2mmol/L L-
Glutamine (Gibco), 250µg/ml Endothelial Cell Growth Supplement (Sigma), 1x 
antibiotic/antimyotic solution (Gibco), and 50µg/mL Gentamycin (Sigma). The cells were 
grown to confluency and passed once a week. They were used at p3, at which they were 
exposed for 5 hours to medium containing 10-7mol/L ET-1, 10-5mol/L BQ-123, or 10-5mol/L 
BQ-788. Control cells were exposed to medium only. Quail cells were used in this in vitro 
study to be able to identify endothelial cells by immunostaining with the QH1 antibody  32. 
Co-staining for actin with 1A4 showed a 70%/30% mixture of endothelial cells and 
myocardium (not shown). 
 
RNA isolation and QRT-PCR 
From each sample total RNA was isolated (RNeasy, Qiagen) and prepared for quantitative 
real time amplification (QRT-PCR). RNA was treated with DNAse-I, and 500ng was reverse 
transcribed into cDNA with M-MuLV Reverse Transcriptase (Amersham). Equal amounts of 
cDNA were subjected in duplicate to QRT-PCR, using SYBR green I Master Mix (Applied 
Biosystems) on an MX3000P PCR machine (Stratagene) 33. The reactions contained 1xPCR 
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Master Mix, 2µl cDNA template, and 10pmol of each primer. As negative controls no-
template samples were used. The PCR program consisted of a hot start activation step of 10 
min 95°C, followed by 50 cycles of 15 sec 95°C, 30 sec 58°C, and 30 sec 72°C. Dissociation 
analysis confirmed the amplification of unique targets and excluded the presence of primer-
dimers. Sequence information of quail mRNAs was largely unavailable, therefore most 
primers in this study were based on chicken primers. The following gene specific primers: 
quail β-actin (GenBank: AF199488), chicken KLF2 (BM490221), chicken ET-1 
(XM418943), chicken ECE-1 (AF230274), and chicken ETA (AF040634), were designed 
using the Primer3 engine at http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi 34. 
Equal amounts of RNA from control and experimental samples were analysed for β-actin 
expression. Ct values did not vary among these groups (not shown); therefore, this gene was 
used as normaliser. Relative expression levels were calculated 35, including gene specific 
values for amplification efficiencies derived from serial dilutions of cDNA and standard curve 
analysis. An independent samples t-test was used to compare the means between control and 
experimental samples. P-values <0.05 were considered significant. 
 
Results 
Doppler Measurements  
Heart rate and cycle length were similar between the study groups and the sham embryos 
(smallest p>0.12). The mean heart rate in the sham embryos was 109 ± 1 bpm corresponding 
to a cycle length of 548 ± 4 ms. Figure 1 demonstrates  that at this heart rate the passive and 
active filling phase of the AV velocity waveform during diastole are well-defined. It is also 
clear that the AV velocity waveform during ventricular systole coincides with the dorsal 
aortic flow velocity. Figure 2 shows all parameters after infusion of the different substances 
compared to shams. 
ET-1: 
Embryos infused with ET-1 demonstrated an increased dorsal aortic blood flow (0.87±0.01 
vs. 0.83±0.01 µl/s, p<0.02). Stroke volume was increased by 3.0%, which was not 
significantly different. The passive ventricular filling volume was decreased by 26.9% 
(p=0.006) and the active filling volume was increased by 16.3% (p<0.01). This resulted in a 
decreased ratio of passive to active ventricular filling (0.30±0.04 vs. 0.45±0.03, p<0.01) after 
ET-1 infusion.  
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ETA receptor antagonist: 
Chicken embryos treated with ETA antagonist had a significantly higher dorsal aortic blood 
flow than sham embryos (0.88±0.02 vs. 0.83±0.01 µl/s, p<0.05). Also dorsal aortic stroke 
volume was elevated by 4.4%. However, this was not a significant difference. The passive 
component of AV blood flow was lower (0.19±0.02 vs. 0.25±0.01 µl/s, p<0.01) in treated 
embryos and the active component higher (0.69±0.03 vs. 0.57±0.01 µl/s, p<0.01). The ratio of 
passive to active ventricular filling was therefore decreased by 36% (p<0.01) after ETA 
antagonist infusion.  
ETB receptor antagonist: 
Chicken embryos treated with ETB antagonist displayed a significantly higher dorsal aortic 
blood flow and stroke volume, i.e. 10.3% and 12.1% higher than sham embryos (p<0.001). 
The passive ventricular filling volume was not different from sham embryos (0.14±0.01 vs. 
0.14±0.01 µl, p=0.5). The active ventricular filling volume was increased by 18.6% 
(p<0.001). This increase however, did not change the ratio of passive to active ventricular 
filling (0.39±0.05 vs. 0.45±0.03, p=0.1).  
Combined ETA/ETB receptor antagonist: 
The combined ETA/ETB antagonist caused an increase in dorsal aortic blood flow of 6.3% 
(p=0.001) and in stroke volume of 5.2% (p<0.01). The passive ventricular filling flow 
component was decreased (0.19±0.01 vs. 0.25±0.01 µl/s, p<0.01) and the active flow 
component was increased (0.69±0.01 vs. 0.57±0.01 µl/s, p<0.001) after infusion with 
ETA/ETB antagonist, resulting in a decreased ratio of passive to active ventricular filling by 
36% (p<0.001). 
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Figure 1. 
An example of simultaneously recorded tracings of atrioventricular flow velocity (black line) and 
dorsal aortic blood flow (grey line) in a sham-operated embryo (A) and ETA antagonist treated 
embryo (B) at HH24. Diastole is portioned into the passive phase (P) and the active phase (A). From 
the figure it is clear that after ETA antagonist infusion the passive component is decreased, whereas 
the active component is increased. 
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Figure 2. 
Effects of ET-1, ETA-, ETB-, and combined ETA/ETB antagonist infusion as compared to sham 
embryos (black line) on dorsal aortic blood flow (panel A), stroke volume (panel B), the passive 
component of atrioventricular blood flow (panel C), the active component of atrioventricular blood 
flow (panel D), and the ratio of passive to active ventricular filling (panel E). *  P < 0.05 vs. shams. 
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Morphology of malformations 
Macroscopically, no major malformations of the heart and pharyngeal arch arteries could be 
observed after infusion of either substance. Microscopically, minor malformations such as 
(pinpoint) ventricular septum defects, hypoplastic pharyngeal arch arteries, and thinner 
ventricular myocardium were encountered (Fig. 3). The total number of minor malformations 
was higher in the experimental embryos than in the shams. In the sham embryos 20% showed 
abnormalities, in the experimental embryos this was 68%, with the highest prevalence in the 
embryos treated with the ETA antagonist (100%), and the lowest prevalence in the ETB 
antagonist treated embryos (40%). Decreased size of the compact layer of the ventricular 
myocardium was the most common malformation occurring in 42% of the experimental 
embryos (50% in ET-1; 75% ETA antagonist; 40% ETB antagonist; 33% ETA/ETB 
antagonist) compared to 20% in sham embryos. 
As VSDs are accompanied by impaired myocardialisation of the outflow tract septum16, this 
was investigated using the anti-muscle actin antibody HHF35. All embryos infused with 
either ET-1, ETA antagonist, ETB antagonist or the combined receptor blocker showed 
normal myocardialisation of the outflow tract (OFT) septum (not shown).  
 
Gene expression 
Normal expression of ETA at stage HH18 was present in all the myocardium of the common 
atrium, the atrioventricular canal (AVC), the ventricle and the outflow tract. During 
development up to HH24 this was the same, all myocardium showed ETA expression (Fig. 4). 
At stage HH18 ETB expression (Fig. 5) was present in the endocardium of the atrium, but 
predominantly on the lateral sides, and on the basal side of the myocardium. In the narrow 
part of the AVC mRNA was also only present in the endocardium at the lateral sides, and in 
the myocardium on the basal side. Going downstream in the AVC the endocardium was 
negative for ETB. The myocardium on the (left) lateral side was positive. The endocardium 
lining the ventricular trabeculations showed strong expression. The myocardium of the 
ventricle was also positive, like the OFT endocardium. During development to HH24 (Fig. 5), 
the endocardial lining of the atria becomes positive. The myocardium of the atria is positive 
predominantly in the ventral/lateral walls. The endocardium of the AVC was negative, like 
the myocardium. The endocardium along the ventricular trabeculations showed strong 
expression, the myocardium surrounding it was also positive. The OFT-myocardium was 
negative, whereas the endocardium showed a patchy expression. 
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Figure 3. 
Sections of HHF35-stained chicken embryonic ventricles at stage HH35. a, b: sham embryo. c, d: 
embryo infused with ET-1. e, f: embryo infused with the ETA/ETB receptor antagonist, and is also 
representative for embryos treated with ETA or ETB blockers. The thickness of the compact 
myocardium is indicated with a line in b, d, and f. Note that the ventricular myocardium is thinner in 
embryos treated with either ET-1 or ET receptor antagonists compared to shams. Bars in a, c and e: 
300µm. Bars in b, d and f: 200 µm. 
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Figure 4. 
ISH sections of a HH18 chicken embryo heart showing ETA (a, c, e) and ETB (b, d, f) mRNA 
expression in adjacent sections. Note that ETA is expressed in the myocardium, and not in the 
endocardium. ETB is predominantly expressed in the endocardium of the common atrium (A; arrows 
in b), narrow part of the atrioventricular canal at the lateral sides (AVC; d), the ventricle (trabecular 
part in f), and outflow tract (OFT; d, f). The distal part of the OFT shows less mRNA (b). The 
downstream part of the AVC also shows little expression (brackets in f). In the myocardium ETB is 
also locally present. The myocardium of the atrium is slightly positive (b), the ventricular yocardium, 
however, shows stronger expression (trabecular part in f). Note the border of positive myocardium in 
the atrium and AVC (arrowheads in b, d, f). Bar is 200µm. 
                                                                  108
 
Figure 5. 
ISH sections of a stage HH24 chicken heart showing ETA (a, c, e) and ETB (b ,d, f) mRNA 
expression. ETA is expressed in myocardium, and not in endocardium. ETB mRNA is predominantly 
present in the endocardium. However, endocardium of the complete atrioventricular canal (AVC) is 
negative (d). The ventricular (V) endocardium is strongly positive (d, f), whereas the endocardium of 
the outflow tract (OFT) shows less expression (b). The myocardium of the left and right atria (LA, 
RA; b) shows slight ETB expression. The myocardium of the AVC is negative (d), whereas the 
ventricular myocardium is positive (f). The compact myocardium shows less mRNA than the 
trabeculations (d). The OFT myocardium is negative (b). Bar is 300µm. 
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In vitro experiments 
The results on gene expression of the addition of ET-1, ETA- or ETB antagonist to cultured 
quail heart endothelial cells (QHEC) for 5 hours is summarized in Figure 6. Application of the 
substances did not result in changes in the expression of KLF2 compared to control cells. 
Exposure to the ETA antagonist, however, showed a significant decrease in ET-1 expression, 
whereas the ETB antagonist resulted in enhancement of ET-1 mRNA. ETA expression appears 
elevated with both ETA and ETB receptor antagonists, although significance was not reached. 
The same accounts for ECE-1 mRNA, where exposure to the ETA receptor antagonist shows 
a significant increase. Addition of ET-1 had no effects on expression of the investigated 
genes. 
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Figure 6. 
Relative quantity of ET-1, ECE-1, ETA and KLF2 mRNA from primary quail endocardial cell cultures 
after a 5-hour administration of ET-1, Endothelin receptor A or B antagonists, or PBS (control). Note 
that ET-1 addition does not lead to changes in mRNA levels. ETA antagonists, however, cause a 
decrease in ET-1 mRNA and an increase of ECE-1 levels; ETA mRNA appears to be increased. ETB 
antagonists show, in contrast to ETA blockers, an increase in ET-1 mRNA. ECE-1 and ETA levels 
appear to be up-regulated as well. KLF2 mRNA is not affected by any of the administered substances. 
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Discussion 
The venous clip model was developed to examine the relation between disturbed blood flow 
and cardiac development. Because the ET-1/ECE-1/ETA pathway has been shown to be 
responsive to changes in blood flow, we investigated whether disturbances in this cascade are 
responsible for both functional cardiac impairment and cardiovascular malformations as seen 
after venous clipping. For this purpose endothelin-1 and endothelin receptor antagonists were 
infused into the blood stream of HH18 embryos and ventricular diastolic filling characteristics 
were studied at HH24, followed by cardiovascular morphologic investigation at HH35. 
Furthermore, the effect of ET-1 and receptor antagonists on expression of ET-1, ECE-1, ETA, 
and KLF2 was investigated. 
 
In vitro experiments  
The in vitro part of this study demonstrates that the different ET-receptor antagonists have the 
same, stimulating effect on ECE-1 and ETA expressions, but a differential effect on ET-1 
mRNA in endocardial and heart muscle cells. While the ETA receptor antagonist causes 
down-regulation of ET-1, the ETB antagonist causes up-regulation. This confirms that ETA 
and ETB receptors act differently within cardiac function 36,37. This was also demonstrated by 
the different reactions to ETA or ETB blockade on the passive filling component.  
 
Doppler measurements 
ET-1 has a negative inotropic and vasodilative effect through the ETB receptor and a positive 
inotropic and vasoconstrictive effect through the ETA receptor 36-39. These effects, however, 
are direct and last for a couple of hours at the most 40,41. Therefore, two days after treatment 
with ET-1 we encounter long-term consequences of this intervention.  
Exogenous ET-1 causes an increase in blood flow probably due to the positive inotropic effect 
of the ETA receptor, which is expressed in the myocardium at both HH18 and 24. The ETB 
receptor is also expressed in the ventricular myocardium at HH18. However, ET-1 has a 
stronger affinity for the ETA receptor. This could explain the dominance of a positive 
inotropic effect through the ETA receptor. Stroke volume is elevated, however not 
significantly. This may be caused by a 2% higher heart rate compared to the shams. The 
passive component of diastolic filling was significantly reduced after ET-1 infusion. This 
might be due to increased collagen synthesis in the heart through both the ETA and ETB 
receptor, leading to a stiffer and less compliant ventricle 42. In response to decreased passive 
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filling cardiac output is maintained by an increased active filling component, which assures 
growth of the embryo. 
Unexpectedly ETA antagonist infusion increases blood flow. As the ETA receptor exerts a 
positive inotropic effect, we expected a diminished blood flow after blocking the receptor. 
Our in vitro data, however, show that when the ETA receptor is blocked, ETA mRNA is up-
regulated, which indicates a compensatory mechanism. Possibly this effect lasts until HH24, 
resulting in a higher blood flow, via the positive inotropic effect of the ETA receptors. Stroke 
volume was elevated as well, however, this was not significant, due to a slightly higher heart 
rate of 1.3% as compared to sham embryos. The following explanation could be found for the 
decreased passive filling component. At HH35 about 50% of the embryos displayed thinner 
ventricles. This suggests that ventricular development is hampered, which could affect passive 
filling. Decreased size of the compact layer of the myocardium has been described in several 
other models, including the antisense Ets and the venous clip model 16,43. The increased active 
component would assure maintenance of cardiac output at an adequate level. Furthermore, an 
increased inotropic state of the atrium due to up-regulation of the ETA receptors could be 
responsible for the latter observation.  
By blocking the ETB receptor and thus the negative inotropic effects, the positive inotropic 
influence of the ETA receptor will prevail, resulting in the demonstrated increased blood flow 
and stroke volume. Growth of the ventricle and its compliance are probably not altered, which 
might explain the unchanged passive filling component. However, the active filling 
component was increased. Normally, the ETB receptors that are present in the atrial 
myocardium and endocardium counteract the positive inotropic effect of the ETA receptors. 
Blocking the ETB receptors could enhance atrial contraction, resulting in increased active 
ventricular filling.  
The combined ETA-ETB antagonist demonstrated increased blood flow and stroke volume. 
Since ETA mRNA is up-regulated after single ETA and single ETB blockade, it is very likely 
that ETA mRNA is also increased after inhibition of both receptors. This will result in a more 
positive inotropic state through the ETA receptor and increased contractility two days after 
infusion of the combined antagonist. ET-1 normally stimulates proliferation of cardiac 
fibroblasts via the ETA receptor 32,44. Therefore, blockade of the ETA receptor may also 
inhibit proliferation in the heart, resulting in decreased ventricular wall thickness. This 
explains the decreased passive filling component as described above. Compensation by the 
increased active component ensures cardiac output.  
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In the venous clip model similar changes in ventricular diastolic filling were demonstrated: 
the passive filling component was reduced by 53 % and the active component was increased 
by 33% after clipping 24. In the present study however, the passive filling component was 
decreased by approximately 25% after infusion with ET-1, ETA- or combined ETA/ETB 
antagonist and the active filling was increased by ± 20%. These results suggest that 
perturbations in the endothelin pathway are responsible for disturbed diastolic filling in the 
venous clip model. However, a single infusion of these substances results in less severe 
diastolic functional impairment compared to the venous clip model, in which the intervention 
is permanent. 
 
Morphology of malformations 
Microscopically minor cardiovascular malformations were encountered after infusion of the 
different substances compared to sham infused embryos. In the venous clip model ET-1 
expression is decreased in the heart after 3 hours (Groenendijk, unpublished), and 
cardiovascular malformations develop 28. These malformations are similar to the ones in 
knockout mice of ET-1, ECE-1 and ETA 27,29,30. Taken together, it would be conceivable that 
infusions of endothelin-1 or endothelin receptor antagonists in particular can lead to major 
malformations. Kempf et al. (1998)45 performed experiments in chicken embryos comparable 
to the present study, and showed malformations of the heart and branchial arch derivatives. 
The anomalies of the branchial arch derivatives were supposed to be neural crest cell (NCC) 
related. In that study an ETA or ETA/ETB antagonist was administered onto the shell 
membrane between HH11 and HH24. In this way the neural crest cells were reached, and 
malformations of the outflow tract and branchial arches, to which NCC migrate, were evoked. 
In our study NCC may not be involved, as endothelin and the antagonists are infused into the 
blood stream, acting from the endothelial side of the vascular system, where they have to pass 
the endothelial barrier. This may explain the absence of these malformations in the present 
study. Another explanation is found in the timing of infusion. Antagonists administered at 
HH11-HH14 displayed the largest number of and the most severe malformations 45. When 
administered during other developmental stages the embryos were much less affected, which 
led to the conclusion that there is a narrow time-window in the development of NCC-derived 
structures in the branchial arches that is ET-1/ECE-1/ETA dependent. Presumably, our 
infusions of antagonists at HH18 were too late to induce major NCC-related malformations.  
In the venous clip model large VSDs are formed in the majority of embryos. A single infusion 
of ET-1, ETA-, ETB-, or a combined receptor antagonist at HH18 does not result in major 
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morphological malformations at HH35. Myocardialisation of the OFT is not impaired. If this 
was the case this would result in a VSD, or at least a delay in closure of the ventricular 
septum, as VSDs and impaired myocardialisation share a common origin 16. Only isolated 
minor malformations are encountered. We assume that multiple infusions may lead to more 
severe cardiac malformations, such as found in the venous clip model, which involves a 
permanent venous ligation and where gene expression can be assumed to be altered for a 
longer period of time. Additionally, endogenous ET-1 is secreted at the abluminal side of the 
endocardial cells 46,47. Therefore, a change in gene expression will have more impact on the 
myocardium than a single administration of ET-1 that is present at the luminal side as a 
consequence of infusion.  
In the venous clip model the permanent ligation of the right lateral vitelline vein alters shear 
stress for at least 5 hrs 4 and subsequently the expression of shear stress responsive genes like 
ET-1, KLF2 and NOS-3 (Groenendijk et al., 2005, unpublished). Thus, after clipping more 
genes will be disturbed than only those involved in the endothelin pathway, and diastolic 
functional changes are stronger. This suggests that the combination of altered hemodynamics 
and gene expression, including those of the endothelin pathway, causes the observed 
cardiovascular malformations after clipping. 
 
In summary 
The results found in the present study suggest that the endothelin pathway is involved in the 
development of functional cardiac impairment present in the venous clip model and plays an 
important role in development of cardiac function in general. We did not observe major 
cardiovascular malformations after infusions of the different substances. Presumably a single 
infusion causes fewer disruptions in cardiac developmental processes than evoked by the 
venous clip intervention. We conclude that cardiovascular malformations after venous 
clipping arise from a combination of hemodynamic changes and subsequent altered gene 
expression patterns, including those of the endothelin pathway. 
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Chapter 6 
General discussion 
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The purpose of the present thesis was to investigate our hypotheses regarding the 
development of cardiovascular malformations in the venous clip model. Firstly, we 
hypothesized that the venous clip intervention leads to instantaneous changes in 
hemodynamic parameters. Secondly, we hypothesized that venous clipping could lead to 
long-term changes in ventricular function. Thirdly, we hypothesized that the endothelin 
cascade is involved in the development of functional cardiac impairment and cardiovascular 
malformations after venous clipping. We used two approaches to obtain different parameters 
of cardiac function at several stages of development. Doppler measurements were made using 
a 20-MHz pulsed Doppler meter. This technique allowed determination of dorsal aortic blood 
flow velocities and ventricular diastolic filling characteristics. Furthermore, intraventricular 
blood pressure and ventricular blood volume were obtained using the servo-null pressure 
system and video imaging with a stereo microscope. This method enabled pressure-volume 
loop reconstruction and analysis, from which intrinsic ventricular systolic and diastolic 
properties were assessed. We used the venous clip chick embryo model, as this intervention 
leads to specific cardiovascular malformations. We suspected that hemodynamics could be 
affected as well, because of the intricate relationship between cardiac morphogenesis and 
cardiac function.  
In figure 1 the findings of the studies presented in this thesis are combined. Starting at the top: 
the venous clip intervention at HH17. This causes an acute decrease in dorsal aortic blood 
volume flow as described in chapter 3. Blood volume flow remains below baseline level for at 
least 5 hrs 1. This leads to a diminished mechanical load on the myocardium of the ventricle. 
Mechanical load regulates ventricular growth 2,3. During normal development the ventricular 
wall volume will increase in size. Hogers et al. observed a delay in ventricular development 
after clipping 4. The venous clip thus probably slows down the ventricular growth and 
differentiation process. This is presumably caused by altered gene expression. Eventually 
cardiovascular malformations are developed 5,6.  
The marked decrease in mean blood flow after clipping also affects shear stress, as shear 
stress depends directly on volume flow 7. Endothelial cells sense these changes in shear stress, 
which lead to alterations in gene expression by activation of a shear stress responsive element 
in the promotor region of the gene 8,9. Groenendijk et al. demonstrated developmental stage- 
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Figure 1. 
Schematic overview of the results presented in this thesis. 
           Represents the venous clip intervention. 
           Represents functional findings after the venous clip intervention (chapter 3, 4 and 5.1). 
           Represents the endothelin-1/antagonist infusion study (chapter 5.2) 
           Represents cardiac malformations caused by venous clipping. 
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related cardiovascular expression of the transcription factor KLF-2 (Krüppel-like factor-2), 
ET-1 (endothelin-1) and NOS-3 (endothelial nitric oxide synthase), which are shear stress 
responsive  genes 10. Gene expression levels 3hrs after clipping confirmed that shear stress is 
diminished in the dorsal aorta. ET-1 expression is increased and KLF-2 and NOS-3 
expression is down- regulated (Groenendijk et al., 2004, unpublished data). The expression of 
ET-1 inside the ventricle is decreased 3hrs after clipping (Groenendijk et al., 2004, 
unpublished data). This is probably caused by a change in intracardiac blood flow patterns, 
which were observed by Hogers et al. leading to local changes in shear stress 5. Especially the 
endothelin-1/ETA signalling cascade appears to be important in cardiovascular development. 
ET-1 has a positive inotropic and vasoconstrictive effect through the ETA receptor 11. 
Knockout mice studies of this cascade demonstrate a spectrum of cardiovascular 
malformations, which strongly resemble those seen in our venous clip model 12-14. As ET-1 
expression is diminished in the heart after clipping, this suggests that the endothelin cascade 
might be involved in the development of the malformations in our model. Ventricular 
development might be impaired due to disturbed expression of these genes. Through the ETA 
receptor, ET-1 mediates proliferation of cardiac fibroblasts of neonatal rats and canines 15,16. 
This contrasts with Hafizi et al. who demonstrated that ET-1 inhibits cell growth in human 
cardiac fibroblasts over a period of 48 hrs while concomitantly being able to stimulate 
collagen synthesis 17. The exact influence of disturbances in ET-1/ETA signalling cascade on 
ventricular development in the chick embryo is not clear yet. This cascade is important in 
other models. Therefore, we assume that in the chick embryo it may also influence ventricular 
development. Reduced mechanical load and/or altered gene expression probably lead to 
delayed or impaired ventricular development.  
Not only ventricular morphology is abnormal. Ventricular function is affected as well. At 
HH21 we demonstrated reduced contractility of the ventricle and the ventricular wall tended 
to be stiffer using pressure-volume loop analysis as described in chapter 4. At HH24 
contractility was even more reduced. This indicates that the mechanism causing a disturbed 
ventricular function is an ongoing process that results in a less contractile ventricle. At HH24 
diastolic stiffness was significantly increased indicating a less compliant ventricle. As the 
embryonic ventricle is relatively non-compliant and compliance increases during development 
18-20, our data suggest that this process lags behind after venous clipping. 
In stage 24 we also observed changes in ventricular diastolic filling using simultaneous 
Doppler measurements of the dorsal aorta and atrioventricular canal, described in chapter 5. A 
reduced diastolic passive-filling component of ventricular filling was compensated by an 
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increased active-filling component in clipped embryos 21. Probably the stiffer ventricular wall 
causes this decrease in passive filling, which is compensated by increased atrial contraction, 
thereby maintaining cardiac output at a sufficient level. Changes in diastolic function may be 
a critical regulatory pathway during cardiac morphogenesis 22. After left atrial ligation 
Schroder et al. demonstrated an increase in microtubule density and β-tubulin protein 3. They 
observed increased myocardial stiffness in response to reduced mechanical load. They argued 
that microtubules mediate the transport of materials necessary for the production of new 
cellular structures. As a consequence they may also play a role in mediating the adaptive 
response of the developing myocardium to altered mechanical load. This also holds for the 
venous clip model since in our model mechanical load is reduced. We assume that changes in 
microtubule density and organisation leads to increased diastolic stiffness in the clipped 
embryos thereby causing reduced diastolic passive ventricular filling.  
In chapter 5 we described the influence of ET-1 and endothelin antagonist infusions on 
diastolic ventricular filling. Changes in ventricular diastolic filling after these infusions are 
similar to the observations made in the venous clip model. This suggests that disturbances in 
the endothelin pathway are responsible for the disturbed diastolic function in the venous clip 
model. However, compared to the venous clip model, diastolic functional impairment is less 
severe, probably due to the short intervention by single infusion of these substances. This also 
explains why we did not observe major cardiovascular malformations after the infusions. 
Presumably a single infusion causes fewer disruptions in cardiac developmental processes 
than the venous clip intervention does. In the venous clip model the permanent ligation of the 
right lateral vitelline vein alters shear stress for at least 5 hrs and subsequently the expression 
of shear stress responsive genes like ET-1, KLF-2 and NOS-3 1(Groenendijk et al. 
unpublished data). Thus, it is conceivable that after clipping more genes are disturbed than 
those involved in the endothelin pathway. This suggests that a combination of altered gene 
expression patterns and hemodynamic changes causes the observed cardiovascular 
malformations after clipping. 
The question arises as to how the results described in this thesis can be linked to the human 
embryo. The most severe human congenital cardiac malformations are already developed 
before we are able to visualise the human embryonic heart in detail using ultrasonography. In 
the majority of cases complex multifactorial genetic factors in combination with 
environmental influences are thought to be responsible 23. We hypothesise that these 
combinations lead to altered gene and protein expression, which in turn result in hampered 
blood flow patterns inside the embryonic heart. Both altered gene expression and hampered 
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blood flow will result in cardiovascular malformations as described in the venous clip model. 
Also disturbed placental development may affect blood flow. Completion of the anatomical 
structure of the embryonic heart coincides with trophoblast invasion and early development of 
the placenta. When the process of trophoblast invasion is disturbed, extra-embryonic blood 
flow may be affected leading to altered flow and shear stress in the embryo, causing 
cardiovascular malformations. 
 
Very recently, the chick genome has been sequenced 24. It contains approximately one billion 
base pairs of sequence and an estimated 20,000-23,000 genes. In future research a prominent 
role for genomics and especially proteomics has to be reserved next to physiological studies 
25,26. These relative new fields of research enable determination of gene expression patterns 
and identification of proteins in the organism. Protein function is determined by the amount 
and structure of the protein. Structural changes in proteins caused by mutations can impair 
their function leading to diseases. It would be interesting to know whether the venous clip 
intervention causes alterations in protein production, and if so what kind of proteins are 
affected. Knowledge of these issues can give more insight into normal and abnormal 
cardiovascular developmental processes in chicks and humans. 
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Summary 
 
Chapter 1 
Congenital heart disease affects approximately 2-3% of children born each year. The 
aetiology of these cardiovascular malformations is still largely unclarified. Knowledge of 
normal and abnormal cardiac development is necessary in order to improve medical and 
surgical outcome. As the present techniques do not allow real-time investigation of early 
cardiac development in human pregnancies, we used the chick embryo as a model. This 
model shares morphological characteristics of the human embryo during early cardiac 
development. Furthermore, an intervention model was available in which specific 
cardiovascular malformations can be induced. By obstructing the right lateral vitelline vein 
(venous clipping) alterations in intracardiac blood flow patterns are caused eventually leading 
to outflow tract anomalies. This model enables investigation of the relationship between 
cardiac morphogenesis and cardiac function as described in this thesis.  
 
Chapter 2 
This chapter deals with the techniques and methods that were used to obtain different 
parameters of cardiac function in the normal and venous clipped chick embryo. The venous 
clip procedure is described. The theory behind Doppler ultrasound and its use in this thesis is 
outlined, as well as the reproducibility of the blood flow velocity waveform recordings. 
Detailed information on the servo-null pressure system and intraventricular blood volume 
measurements is presented. Assessment of ventricular function is obtained by analysis of 
pressure-volume loops.  
 
Chapter 3 
The instantaneous effects of clipping the right lateral vitelline vein on blood volume flow in 
the stage 17-chick embryo was studied using dorsal aortic Doppler measurements. Heart rate, 
peak systolic velocity, time-averaged velocity, peak blood flow, mean blood flow, peak 
acceleration and stroke volume decreased acutely after venous clipping and only three out of 
seven parameters (heart rate, time-averaged velocity and mean blood flow) showed a recovery 
to baseline values during the 5 h study period. The venous clip intervention has major acute 
effects on hemodynamics in the chick embryo. These effects may be responsible for the 
observed cardiac malformations after clipping. 
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Chapter 4 
Long-term consequences of the venous clip intervention for ventricular function were 
determined one day (HH21) and two days (HH24) after clipping using pressure-volume loop 
analysis. At HH21 steady state hemodynamic parameters demonstrated no significant 
differences between the venous clipped and control embryos. However analysis of pressure-
volume relations showed a significantly lower end-systolic elastance in the clipped embryos 
indicating reduced contractility. Diastolic stiffness tended to be increased after clipping but 
the difference did not reach statistical significance. At HH24 end-systolic volume was 
significantly higher in clipped embryos. End-systolic pressure and end-diastolic pressure were 
also increased. No significant differences were demonstrated for other baseline hemodynamic 
parameters. Analysis of pressure-volume relations showed a significantly lower end-systolic 
elastance in the clipped embryos indicating reduced contractility. Diastolic stiffness was 
significantly increased indicating reduced compliance. 
These findings support the hypothesis that development of ventricular function in the 
embryonic heart is affected by mechanical load. Venous obstruction interferes with normal 
myocardial development resulting in impaired intrinsic systolic and diastolic ventricular 
function. Changes in ventricular function may precede morphological derangements in later 
developmental stages. 
 
Chapter 5 
The first part of this chapter describes the study on the influence of the venous clip 
intervention on ventricular diastolic filling using simultaneous Doppler measurements over 
the dorsal aorta and atrioventricular canal. At similar cycle lengths dorsal aortic blood flow 
and stroke volume measured in the dorsal aorta were comparable in HH24 clipped and normal 
embryos. Passive filling volume was decreased with 53% and active filling volume was 
increased with 33% in the clipped embryos, leading to a decreased passive/active ratio. These 
results suggest that material properties of the embryonic ventricle are modified after 
temporarily reduced hemodynamic load. In conclusion, early venous obstruction results in 
altered diastolic ventricular filling in the stage 24-chick embryo. Changes in cardiac function 
and structure can be produced by alterations in mechanical loading. 
In the second part of the chapter the same simultaneous Doppler measurements were 
performed after infusion of endothelin-1 or endothelin receptor antagonist. The passive filling 
component was decreased with approximately 25% after infusion with ET-1, ETA- or 
combined ETA/ETB receptor antagonist. The active filling was increased with ± 20%. These 
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changes in ventricular diastolic filling are similar to the observations made in the venous clip 
model. This suggests that disturbances in the endothelin pathway are responsible for the 
impaired diastolic function in the venous clip model. We did not observe major 
cardiovascular malformations after the infusions. Presumably a single infusion causes fewer 
disruptions in cardiac developmental processes than the venous clip intervention does. The 
combination of altered gene expression patterns and hemodynamic changes probably causes 
the observed cardiovascular malformations after clipping. 
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Samenvatting 
 
Hoofdstuk 1 
Ieder jaar wordt bij 2-3% van de pasgeborenen een congenitale hartafwijking geconstateerd. 
De oorzaak van deze cardiovasculaire afwijkingen is grotendeels onbekend. Kennis van 
normale en abnormale hartontwikkeling is nodig om de uitkomst van medische en 
chirurgische behandeling te verbeteren. Omdat de huidige beeldvormende technieken 
ontoereikend zijn om vroege hartontwikkeling te bestuderen in de mens hebben we 
gebruikgemaakt van het kippenembryo model. De morphologische eigenschappen van dit 
model komen overeen met die van de mens tijdens vroege hartontwikkeling. We beschikken 
daarnaast over een interventie model waarin specifieke cardiovasculaire afwijkingen kunnen 
worden geïnduceerd. Door de rechter laterale vitelline vene af te klemmen (veneus clippen) 
worden veranderingen in intracardiale bloedstroomprofielen veroorzaakt, wat uiteindelijk 
leidt tot afwijkingen in het uitstroomgebied.  Dit model maakt het mogelijk om de relatie 
tussen morphologie van het hart en hartfunctie te onderzoeken zoals beschreven in dit 
proefschrift. 
 
Hoofdstuk 2 
Dit hoofdstuk behandelt de technieken en methodes welke gebruikt zijn om de verschillende 
hartfunctie parameters te verkrijgen in normale en veneus geclipte kippenembryo’s. De 
veneuze clip procedure wordt beschreven. Zowel de theorie achter Doppler echografie en het 
gebruik hiervan in dit proefschrift wordt uiteengezet, als ook de reproduceerbaarheid van 
bloeddoorstroming snelheidsmetingen. Gedetailleerd worden het servo-null druksysteem en 
de intraventriculaire bloedvolume metingen beschreven. Ventrikelfunctie wordt vastgesteld 
met behulp van druk-volume relaties. 
 
Hoofdstuk 3 
De directe effecten van het clippen van de rechter laterale vitelline vene in het stadium 17 
kippenembryo op bloedvolume doorstroming werden bestudeerd met behulp van dorsale aorta 
Doppler metingen. Hartslag, maximale systolische doorstromingssnelheid, gemiddelde 
systolische doorstromingssnelheid, maximaal doorstromingsvolume, gemiddeld 
doorstromingsvolume, maximale acceleratie en slagvolume zijn acuut verlaagd na veneus 
clippen en slechts drie van de zeven parameters (hartslag, gemiddelde systolische 
doorstromingssnelheid en gemiddeld doorstromingsvolume) herstelden zich tot baseline 
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waarden tijdens de 5 uur durende studieperiode. De veneuze clip interventie heeft grote 
gevolgen voor de hemodynamiek in het kippenembryo. Dit zou de oorzaak kunen zijn voor de 
waargenomen hartafwijkingen na clippen. 
 
Hoofdstuk 4 
Lange termijn gevolgen van de veneuze clip interventie voor ventrikelfunctie werden 
vastgesteld één dag (HH21) en twee dagen (HH24) na clippen door middel van druk-volume 
relatie analyse. In HH21 toonden de basis hemodynamische parameters geen significante 
verschillen tussen de veneus geclipte en controle embryo’s. Maar analyse van druk-volume 
relaties liet een significant lagere eind-systolische elasticiteit in de geclipte embryo’s zien, wat  
wijst op een verlaagde contractiliteit. Diastolische stijfheid was verhoogd na clippen, maar 
niet significant. In HH24 was het eind-systolische volume significant hoger in geclipte 
embryo’s. Eind-systolische druk en eind-diastolische druk waren ook verhoogd. Voor overige 
basis hemodynamische parameters werden geen significante verschillen gevonden. Analyse 
van de druk-volume relaties toonde een significant lagere eind-systolische elasticiteit en dus 
contractiliteit. Diastolische stijfheid was significant verhoogd, dit duidt op een verminderde 
compliantie. 
Deze bevindingen ondersteunen de hypothese dat ontwikkeling van ventrikelfunctie in het 
embryonale hart wordt beïnvloed door mechanische lading. Veneuze obstructie interfereert 
met normale myocardiale ontwikkeling resulterend in gestoorde intrinsieke systolische en 
diastolische ventrikelfunctie. Veranderingen in ventrikelfunctie kunnen voorafgaan aan 
morphologische afwijkingen in latere ontwikkelingsstadia. 
 
Hoofdstuk 5 
Het eerste deel van dit hoofdstuk beschrijft de studie naar de invloed van de veneuze clip 
interventie op ventriculaire diastolische vulling door middel van simultane Doppler metingen 
over de dorsale aorta en het atrioventriculaire kanaal. Bij een gelijke hartcycluslengte waren 
bloeddoorstromingsvolume en slagvolume, gemeten in de dorsale aorta, vergelijkbaar in 
geclipte en normale embryo’s van HH24. Het passieve vullingsvolume was afgenomen met 
53% en het actieve vullingsvolume was toegenomen met 33% in geclipte embryo’s, wat 
resulteerde in een verlaagde passieve/actieve ratio. Deze resultaten suggereren dat materiaal 
eigenschappen van het embryonale ventrikel zijn veranderd na tijdelijk verlaagde 
mechanische lading. 
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In het tweede deel van dit hoofdstuk werden dezelfde simultane Doppler metingen verricht na 
infusie van endotheline-1 of endotheline receptor antagonisten. De passieve 
vullingscomponent was verlaagd met ongeveer 25% na infusie met ET-1, ETA- of 
gecombineerde ETA/ETB receptor antagonist. De actieve vulling was verhoogd met ± 20%. 
Deze veranderingen in ventriculaire diastolische vulling zijn vergelijkbaar met bevindingen in 
het veneuze clip model. Dit suggereert dat verstoringen in de endotheline cascade 
verantwoordelijk zijn voor  de afwijkende diastolische functie in het veneuze clip model. We 
vonden geen grote cardiovasculaire afwijkingen na de infusies. Het is aannemelijk dat een 
enkele infusie minder verstoringen in het hartontwikkelingsproces veroorzaakt dan de 
veneuze clip interventie. De combinatie van veranderde genexpressiepatronen en 
hemodynamische veranderingen leidt waarschijnlijk tot de gevonden cardiovasculaire 
afwijkingen na clippen. 
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